Nancy L. Ascher, MD, PhD

Institution	Degree	Dept or School	End Date
University of Minnesota	Fellowship	Transplant Surgery	1982
University of Minnesota	Residency	General Surgery	1981
University of Michigan			1974

Grants and Funding

ALLOGRAFT RESPONSE TO LIVER TISSUE | NIH | 1988-09-30 - 1995-09-29 | Role: Principal Investigator
LIVER TRANSPLANTATION CENTERS | NIH/NIDDK | 1990-01-01 - 1995-03-31 | Role: Principal Investigator
ORGAN TRANSPLANTS: ANALYSIS OF MIGRATING LYMPHOCYTES | NIH | 1984-07-01 - 1987-06-30 | Role: Principal Investigator

Research Narrative

I. RECURRENT DISEASE AFTER LIVER TRANSPLANT
The NIH Liver Transplant Data Base has been extended to address the important issue of disease recurrence after liver transplantation. Although short term liver transplant results have improved markedly over the past ten years, it is apparent that disease recurrence is an important source of patient morbidity and graft loss. Long term following of greater than 1000 patients in the Liver Transplant Data Base will facilitate our understanding of the factors associated with graft recurrence.

II. EXPANDED CRITERIA FOR LIVER TRANSPLANT FOR HEPATOCELLULAR CARCINOMA
We have redefined the criteria for liver transplantation beyond the Milan criteria. The UCSF criteria enables additional patients to benefit from liver transplants without compromising outcome.

Research Interests

Clinical Transplantation
Recurrence After Liver Transplantation
Transplant Policy
Transplant Ethics

Publications

MOST RECENT PUBLICATIONS FROM A TOTAL OF 428

The potential of kidney transplantation to reduce mortality from chronic kidney disease: a global, cross-sectional, modelling study.
Zambeli-Ljepovic A, Tungsanga S, Ghimire A, Bello AK, Okpechi IG, Siyoum MT, Mushi FA, Asiimwe F, Bagasha P, Okungu V, Bertozzi SM, Hoffmann TJ, Thomson D, Muller E, Scott JW, Syed S, Ascher N, Stock P, Rose J| 2025-08-27 | PubMed
Back Table Arterial Reconstructions Using the Recipient Hepatic Arterial Tree in Living Donor Liver Transplantation.
Stacey P, Braun H, Barua S, Tavakol M, Piper M, Ascher N, Roberts J| 2025-07-01 | PubMed
Proposed US Legislation to Pay Kidney Donors: Counter-productive and Against Global Ethical Standards.
Capron AM, Danovitch GM, Cooper M, Ascher NL, Delmonico FL| 2024-10-31 | PubMed
Promoting Equitable and Affordable Patient Access to Safe and Effective Innovations in Donation and Transplantation of Substances of Human Origin and Derived Therapies.
Cuende N, Tullius SG, Izeta A, Plattner V, Börgel MSc M, Ciccocioppo R, Correa-Rocha R, Koh MBC, De Angelis V, Gondolesi GE, Ten Ham R, Porte RJ, Hernández-Maraver D, Hawthorne WJ, Sureda A, Orlando G, Haraldsson B, Ascher NL, Dominguez-Gil B, Oniscu GC| 2024-10-22 | PubMed
A Last Hurrah: Reply to Sharif et al Regarding China.
Delmonico FL, Ascher NL| 2024-05-23 | PubMed
Anesthesia and Critical Care for the Prediction and Prevention for Small-for-size Syndrome: Guidelines from the ILTS-iLDLT-LTSI Consensus Conference.
Chadha R, Sakai T, Rajakumar A, Shingina A, Yoon U, Patel D, Spiro M, Bhangui P, Sun LY, Humar A, Bezinover D, Findlay J, Saigal S, Singh S, Yi NJ, Rodriguez-Davalos M, Kumar L, Kumaran V, Agarwal S, Berlakovich G, Egawa H, Lerut J, Clemens Broering D, Berenguer M, Cattral M, Clavien PA, Chen CL, Shah S, Zhu ZJ, Ascher N, Bhangui P, Rammohan A, Emond J, Rela M| 2023-09-25 | PubMed
Management of Established Small-for-size Syndrome in Post Living Donor Liver Transplantation: Medical, Radiological, and Surgical Interventions: Guidelines From the ILTS-iLDLT-LTSI Consensus Conference.
Kirchner VA, Shankar S, Victor DW, Tanaka T, Goldaracena N, Troisi RI, Olthoff KM, Kim JM, Pomfret EA, Heaton N, Polak WG, Shukla A, Mohanka R, Balci D, Ghobrial M, Gupta S, Maluf D, Fung JJ, Eguchi S, Roberts J, Eghtesad B, Selzner M, Prasad R, Kasahara M, Egawa H, Lerut J, Broering D, Berenguer M, Cattral MS, Clavien PA, Chen CL, Shah SR, Zhu ZJ, Ascher N, Ikegami T, Bhangui P, Rammohan A, Emond JC, Rela M| 2023-09-25 | PubMed
Post Living Donor Liver Transplantation Small-for-size Syndrome: Definitions, Timelines, Biochemical, and Clinical Factors for Diagnosis: Guidelines From the ILTS-iLDLT-LTSI Consensus Conference.
Kow AWC, Liu J, Patel MS, De Martin E, Reddy MS, Soejima Y, Syn N, Watt K, Xia Q, Saraf N, Kamel R, Nasralla D, McKenna G, Srinvasan P, Elsabbagh AM, Pamecha V, Palaniappan K, Mas V, Tokat Y, Asthana S, Cherukuru R, Egawa H, Lerut J, Broering D, Berenguer M, Cattral M, Clavien PA, Chen CL, Shah S, Zhu ZJ, Emond J, Ascher N, Rammohan A, Bhangui P, Rela M, Kim DS, Ikegami T, ILTS-iLDLT-LTSI SFSS Working Group| 2023-09-25 | PubMed
DCD liver transplant in patients with a MELD over 35.
Meier RPH, Nunez M, Syed SM, Feng S, Tavakol M, Freise CE, Roberts JP, Ascher NL, Hirose R, Roll GR| 2023-09-04 | PubMed
Preventing Small-for-size Syndrome in Living Donor Liver Transplantation: Guidelines From the ILTS-iLDLT-LTSI Consensus Conference.
Hakeem AR, Mathew JS, Aunés CV, Mazzola A, Alconchel F, Yoon YI, Testa G, Selzner N, Sarin SK, Lee KW, Soin A, Pomposelli J, Menon K, Goyal N, Kota V, Abu-Gazala S, Rodriguez-Davalos M, Rajalingam R, Kapoor D, Durand F, Kamath P, Jothimani D, Sudhindran S, Vij V, Yoshizumi T, Egawa H, Lerut J, Broering D, Berenguer M, Cattral M, Clavien PA, Chen CL, Shah S, Zhu ZJ, Ascher N, Bhangui P, Rammohan A, Emond J, Rela M| 2023-08-28 | PubMed
Organ Donation and Transplantation in China.
Ascher NL, Delmonico FL| 2023-08-21 | PubMed
Sex-based Disparities in Access to Liver Transplantation for Waitlisted Patients With Model for End-stage Liver Disease Score of 40.
Cron DC, Braun HJ, Ascher NL, Yeh H, Chang DC, Adler JT| 2023-06-27 | PubMed
Comments on Experience With Establishing a Robotic Donor Hepatectomy Program for Pediatric Liver Transplantation.
Ascher NL, Roberts JP| 2023-06-09 | PubMed
The John S. Najarian symposium: The past, present, and future of surgery and transplantation, May 20, 2022, Minneapolis, MN.
Knatterud ME, Simmons RL, Payne W, Stock P, Chavers B, Ascher N, Kaufman D, Kirk A, Keshavjee S, Humar A, Ganesh S, Hughes C, Kandaswamy R, Matas AJ| 2023-03-01 | PubMed
Addressing sex-based disparities in solid organ transplantation in the United States - a conference report.
Sawinski D, Lai JC, Pinney S, Gray AL, Jackson AM, Stewart D, Levine DJ, Locke JE, Pomposelli JJ, Hartwig MG, Hall SA, Dadhania DM, Cogswell R, Perez RV, Schold JD, Turgeon NA, Kobashigawa J, Kukreja J, Magee JC, Friedewald J, Gill JS, Loor G, Heimbach JK, Verna EC, Walsh MN, Terrault N, Testa G, Diamond JM, Reese PP, Brown K, Orloff S, Farr MA, Olthoff KM, Siegler M, Ascher N, Feng S, Kaplan B, Pomfret E| 2023-01-12 | PubMed
Comparison of Biliary Complications Rates After Brain Death, Donation After Circulatory Death, and Living-Donor Liver Transplantation: A Single-Center Cohort Study.
Meier RPH, Kelly Y, Braun H, Maluf D, Freise C, Ascher N, Roberts J, Roll G| 2022-12-09 | PubMed
The Reality of Inadequate Patient Care and the Need for a Global Action Framework in Organ Donation and Transplantation.
Domínguez-Gil B, Ascher NL, Fadhil RAS, Muller E, Cantarovich M, Ahn C, Berenguer M, Bušic M, Egawa H, Gondolesi GE, Haberal M, Harris D, Hirose R, Ilbawi A, Jha V, López-Fraga M, Andrés Madera S, Najafizadeh K, O'Connell PJ, Rahmel A, Shaheen FAM, Twahir A, Van Assche K, Wang H, Haraldsson B, Chatzixiros E, Delmonico FL| 2022-10-21 | PubMed
Optimizing pre-donation physiologic evaluation for enhanced recovery after living liver donation - Systematic review and multidisciplinary expert panel recommendations.
Izzy M, Brown RS, Eguchi S, Hwang S, Matamoros MA, Quintini C, Rajakumar A, Raptis DA, Spiro M, Ascher NL, ERAS4OLT.org Working Group| 2022-10-01 | PubMed
Novel Benchmark Values for Redo Liver Transplantation: Does the Outcome Justify the Effort?
Abbassi F, Gero D, Muller X, Bueno A, Figiel W, Robin F, Laroche S, Picard B, Shankar S, Ivanics T, van Reeven M, van Leeuwen OB, Braun HJ, Monbaliu D, Breton A, Vachharajani N, Bonaccorsi Riani E, Nowak G, McMillan RR, Abu-Gazala S, Nair A, Bruballa R, Paterno F, Weppler Sears D, Pinna AD, Guarrera JV, de Santibañes E, de Santibañes M, Hernandez-Alejandro R, Olthoff K, Ghobrial RM, Ericzon BG, Ciccarelli O, Chapman WC, Mabrut JY, Pirenne J, Müllhaupt B, Ascher NL, Porte RJ, de Meijer VE, Polak WG, Sapisochin G, Attia M, Soubrane O, Weiss E, Adam RA, Cherqui D, Boudjema K, Zieniewicz K, Jassem W, Dutkowski P, Clavien PA| 2022-07-27 | PubMed
A novel microsurgical reconstruction technique in a living-related liver donor hepatic artery dissection using the native hepatic artery.
Sitta R, Roberts J, Gardner J, Ascher N, Piper M| 2022-06-14 | PubMed
Long-term Outcomes Following Kidney and Liver Transplant in Recipients With HIV.
Zarinsefat A, Gulati A, Shui A, Braun H, Rogers R, Hirose R, Ascher N, Stock P| 2022-03-01 | PubMed
International Travel for Liver Transplantation: A Comprehensive Assessment of the Impact on the United States Transplant System.
Braun HJ, Amara D, Shui AM, Stock PG, Hirose R, Delmonico FL, Ascher NL| 2022-02-01 | PubMed
Advantages and Limitations of Clinical Scores for Donation After Circulatory Death Liver Transplantation.
Meier RPH, Kelly Y, Yamaguchi S, Braun HJ, Lunow-Luke T, Adelmann D, Niemann C, Maluf DG, Dietch ZC, Stock PG, Kang SM, Feng S, Posselt AM, Gardner JM, Syed SM, Hirose R, Freise CE, Ascher NL, Roberts JP, Roll GR| 2022-01-05 | PubMed
Expedited evaluation for liver transplantation: A critical look at processes and outcomes.
Braun HJ, Mello A, Kothari R, Ku E, Yilma M, Tavakol M, Zhang L, Niemann CU, Ascher NL, Adelmann D| 2021-12-23 | PubMed
Travel for Transplantation: A Review of Domestic and International Travel for Liver Transplantation in the United States.
Braun HJ, Ascher NL| 2021-12-07 | PubMed
Surgical Trainee Well-Being: A Synergy of Individual and System-Level Interventions.
Greenberg AL, Collins CR, Rosser ML, Ascher NL, O'Sullivan PS, Reilly LM, Lebares CC| 2021-11-01 | PubMed
Correction to: Expanding controlled donation after the circulatory determination of death: statement from an international collaborative.
Domínguez-Gil B, Ascher N, Capron AM, Gardiner D, Manara AR, Bernat JL, Miñambres E, Singh JM, Porte RJ, Markmann JF, Dhital K, Ledoux D, Fondevila C, Hosgood S, Van Raemdonck D, Keshavjee S, Dubois J, McGee A, Henderson GV, Glazier AK, Tullius SG, Shemie SD, Delmonico FL| 2021-09-01 | PubMed
Meeting Report: First State of the Art Meeting on Gender Disparity in Kidney Transplantation in the Asia-Pacific.
Kim Y, Ahmed E, Ascher N, Danguilan R, Hooi LS, Hustrini NM, Kim YH, Kute V, Rosete-Liquete RMO, Ma M, Mannon RB, Nakagawa Y, Od-Erdne L, Ramesh V, Rashid HU, Thangaraju S, Thwin KT, Vathsala A, West L, Win KK, Ahn C, Wong G| 2021-09-01 | PubMed
"The use of bilateral continuous erector spinae plane blocks for postoperative analgesia after right-sided living donor hepatectomy: A feasibility study".
Adelmann D, Khorashadi M, Zhou G, Kinjo S, Braun HJ, Ascher NL, Braehler MR| 2021-07-19 | PubMed
Retransplantation After Living Donor Liver Transplantation: Data from the Adult to Adult Living Donor Liver Transplantation Study.
Braun HJ, Grab JD, Dodge JL, Syed SM, Roll GR, Schwab MP, Liu IH, Glencer AC, Freise CE, Roberts JP, Ascher NL| 2021-06-01 | PubMed
Obesity is a risk factor for progression to kidney transplant waitlisting after liver transplantation.
Locke JE, Shelton B, Orandi B, Olthoff K, Pomfret E, Forde KA, Sawinski D, Gray M, Ascher N| 2021-05-05 | PubMed
The Importance of Bringing Transplantation Tolerance to the Clinic.
Cosimi AB, Ascher NL, Emond JC, Kaufman DB, Madsen JC, Miller J, Monaco AP, Montgomery RA, Newell KA, Sánchez-Fueyo A, Sarwal MM, Scandling JD, Strober S, Todo S, Weir MR, Sachs DH| 2021-05-01 | PubMed
Standardizing Discharge Opioid Prescriptions in Kidney Transplant Patients Decreases Opioid Usage.
Schwab ME, Braun HJ, Quan D, Roll GR, Budanova N, Ascher NL, Hirose R| 2021-04-30 | PubMed
Live Donor Liver Transplantation in the United States: Impact of Share 35 on Live Donor Utilization.
Braun HJ, Dodge JL, Grab JD, Schwab ME, Liu IH, Glencer AC, Stock PG, Hirose R, Roberts JP, Ascher NL| 2021-04-01 | PubMed
Enhanced Stress Resilience Training in Surgeons: Iterative Adaptation and Biopsychosocial Effects in 2 Small Randomized Trials.
Lebares CC, Coaston TN, Delucchi KL, Guvva EV, Shen WT, Staffaroni AM, Kramer JH, Epel ES, Hecht FM, Ascher NL, Harris HW, Cole SW| 2021-03-01 | PubMed
Expanding controlled donation after the circulatory determination of death: statement from an international collaborative.
Domínguez-Gil B, Ascher N, Capron AM, Gardiner D, Manara AR, Bernat JL, Miñambres E, Singh JM, Porte RJ, Markmann JF, Dhital K, Ledoux D, Fondevila C, Hosgood S, Van Raemdonck D, Keshavjee S, Dubois J, McGee A, Henderson GV, Glazier AK, Tullius SG, Shemie SD, Delmonico FL| 2021-02-26 | PubMed
A world-wide survey on kidney transplantation practices in breast cancer survivors: The need for new management guidelines.
Hansen KS, Ghersin H, Piper M, Tavakol M, Lee B, Esserman LJ, Roberts JP, Freise C, Ascher NL, Mukhtar RA| 2021-02-08 | PubMed
Exploration of Individual and System-Level Well-being Initiatives at an Academic Surgical Residency Program: A Mixed-Methods Study.
Lebares CC, Greenberg AL, Ascher NL, Delucchi KL, Reilly LM, van der Schaaf M, Baathe F, O'Sullivan P, Isaksson Rø K| 2021-01-04 | PubMed
Opioid Use and Liver Transplantation.
Braun HJ, Ascher NL| 2021-01-01 | PubMed
Setting rules for the sandbox: A response to "Successfully sharing the sandbox: A perspective on combined DCD liver and heart donor procurement".
Wisel SA, Thiessen C, Day R, Belin LJ, Syed SM, Hirose R, Ascher N, Roberts JP, Freise CE| 2020-12-25 | PubMed
Expanding living donor liver transplantation: Report of first US living donor liver transplant chain.
Braun HJ, Torres AM, Louie F, Weinberg SD, Kang SM, Ascher NL, Roberts JP| 2020-12-08 | PubMed
Opioid use prior to liver transplant is associated with increased risk of death after transplant.
Braun HJ, Schwab MP, Jin C, Amara D, Mehta NJ, Grace TR, Croci R, Freise CE, Roberts JP, Hirose R, Ascher NL| 2020-11-20 | PubMed
COVID-19 and Abdominal Transplant: A Stepwise Approach to Practice During Pandemic Conditions.
Syed SM, Gardner J, Roll G, Webber A, Mehta N, Shoji J, Adelmann D, Niemann C, Braun HJ, Mello A, Yao F, Posselt A, Kang SM, Hirose R, Roberts J, Feng S, Ascher N, Stock P, Freise C| 2020-11-01 | PubMed
Global Transplantation COVID Report March 2020.
Ahn C, Amer H, Anglicheau D, Ascher NL, Baan CC, Battsetset G, Bat-Ireedui B, Berney T, Betjes MGH, Bichu S, Birn H, Brennan D, Bromberg J, Caillard S, Cannon RM, Cantarovich M, Chan A, Chen ZS, Chapman JR, Cole EH, Cross N, Durand F, Egawa H, Emond JC, Farrero M, Friend PJ, Geissler EK, Ha J, Haberal MA, Henderson ML, Hesselink DA, Humar A, Jassem W, Jeong JC, Kaplan B, Kee T, Kim SJ, Kumar D, Legendre CM, Man K, Moulin B, Muller E, Munkhbat R, Od-Erdene L, Perrin P, Rela M, Tanabe K, Tedesco Silva H, Tinckam KT, Tullius SG, Wong G| 2020-10-01 | PubMed
Training of Male and Female Surgical Residents.
Braun HJ, Ascher NL| 2020-10-01 | PubMed
Author's Response.
Delmonico FL, Dominguez-Gil B, Ascher NL, Glazier AK, Henderson GV, Bernat JL| 2020-07-01 | PubMed
Implementing an opioid reduction protocol in renal transplant recipients.
Schwab ME, Braun HJ, Ascher NL, Hirose R| 2020-07-01 | PubMed
Quantifying Sex-Based Disparities in Liver Allocation.
Locke JE, Shelton BA, Olthoff KM, Pomfret EA, Forde KA, Sawinski D, Gray M, Ascher NL| 2020-07-01 | PubMed
A Virtual Crossmatch-based Strategy Facilitates Sharing of Deceased Donor Kidneys for Highly Sensitized Recipients.
Roll GR, Webber AB, Gae DH, Laszik Z, Tavakol M, Mayen L, Cunniffe K, Syed S, Hirose R, Freise C, Feng S, Roberts JP, Ascher NL, Stock PG, Rajalingam R| 2020-06-01 | PubMed
Living Donor Liver Transplant for Alcoholic Liver Disease: Data from the Adult-to-adult Living Donor Liver Transplantation Study.
Braun HJ, Dodge JL, Grab JD, Syed SM, Roll GR, Freise CE, Roberts JP, Ascher NL| 2020-02-01 | PubMed
Key factors for implementing mindfulness-based burnout interventions in surgery.
Lebares CC, Guvva EV, Desai A, Herschberger A, Ascher NL, Harris HW, O'Sullivan P| 2019-10-17 | PubMed
The Utility of ECMO After Liver Transplantation: Experience at a High-volume Transplant Center and Review of the Literature.
Braun HJ, Pulcrano ME, Weber DJ, Padilla BE, Ascher NL| 2019-08-01 | PubMed
Glass Slippers and Glass Cliffs: Fitting In and Falling Off.
Krishnan N, Biggerstaff D, Szczepura A, Dolton M, Livingston S, Hattersley J, Eris J, Ascher N, Higgins R, Braun H, Wood K, Raymond N| 2019-07-01 | PubMed
Societal and Professional Obligation in the Care of the Living Organ Donor.
Ascher NL, Delmonico FL| 2019-06-01 | PubMed
Bi-organ paired exchange-Sentinel case of a liver-kidney swap.
Torres AM, Wong F, Pearson S, Weinberg S, Roberts JP, Ascher NL, Freise CE, Lee BK| 2019-05-08 | PubMed
Efficacy of Mindfulness-Based Cognitive Training in Surgery: Additional Analysis of the Mindful Surgeon Pilot Randomized Clinical Trial.
Lebares CC, Guvva EV, Olaru M, Sugrue LP, Staffaroni AM, Delucchi KL, Kramer JH, Ascher NL, Harris HW| 2019-05-03 | PubMed
Call for an End to Unethical Transplant Practices: A Concerted Effort by the Transplant Community.
Haberal M, Cantarovich M, Muller E, Fung JJ, Sarwal M, Tullius SG, Ascher N| 2019-04-01 | PubMed
Feasibility of Formal Mindfulness-Based Stress-Resilience Training Among Surgery Interns: A Randomized Clinical Trial.
Lebares CC, Hershberger AO, Guvva EV, Desai A, Mitchell J, Shen W, Reilly LM, Delucchi KL, O'Sullivan PS, Ascher NL, Harris HW| 2018-10-01 | PubMed
Deceased Donor Organ Transplantation Performed in the United States for Noncitizens and Nonresidents.
Delmonico FL, Gunderson S, Iyer KR, Danovitch GM, Pruett TL, Reyes JD, Ascher NL| 2018-07-01 | PubMed
The Impact of Renal Insufficiency After Liver Transplantation.
Braun HJ, Ascher NL| 2018-07-01 | PubMed
Living Donor Liver Transplantation for Alcoholic Liver Disease.
Braun HJ, Ascher NL| 2018-03-01 | PubMed
A Formula to Calculate Standard Liver Volume Using Thoracoabdominal Circumference.
Shaw BI, Burdine LJ, Braun HJ, Ascher NL, Roberts JP| 2017-10-27 | PubMed
Burnout and Stress Among US Surgery Residents: Psychological Distress and Resilience.
Lebares CC, Guvva EV, Ascher NL, O'Sullivan PS, Harris HW, Epel ES| 2017-10-26 | PubMed
Opposition to irresponsible global kidney exchange.
Delmonico FL, Ascher NL| 2017-09-02 | PubMed
Clinical Trials for Immunosuppression in Transplantation: The Case for Reform and Change in Direction.
O'Connell PJ, Kuypers DR, Mannon RB, Abecassis M, Chadban SJ, Gill JS, Murphy B, Nickerson PW, Schold JD, Stock PG, Seron D, Alloway RR, Bromberg JS, Budde K, Jordan SC, Legendre C, Lefaucheur C, Sarwall M, Segev DL, Stegall MD, Tullius SG, Wong G, Woodle ES, Ascher N, Morris RE| 2017-07-01 | PubMed
Criminal Organ Retrieval: Unconscionable.
Pruett TL, Vathsala A, Berney T, Lerut J, Odorico JS, Johnson M, Egawa H, Gonzalez-Martinez F, Haberal M, Ascher NL, Chandraker AK| 2016-10-03 | PubMed
The Transplantation Society Believes a Policy of Engagement Will Facilitate Organ Donation Reform in China.
O'Connell PJ, Ascher N, Delmonico FL| 2016-10-03 | PubMed
Biliary complications following living donor hepatectomy.
Braun HJ, Ascher NL, Roll GR, Roberts JP| 2016-07-18 | PubMed
Impact of Graft Selection on Donor and Recipient Outcomes After Living Donor Liver Transplantation.
Braun HJ, Dodge JL, Roll GR, Freise CE, Ascher NL, Roberts JP| 2016-06-01 | PubMed
Medical Students' Perceptions of Surgeons: Implications for Teaching and Recruitment.
Braun HJ, Dusch MN, Park SH, O'Sullivan PS, Harari A, Harleman E, Ascher NL| 2015-07-15 | PubMed
Nancy L. Ascher, MD, PhD: Professor and Chair, Department of Surgery, UCSF; Past-President, ASTS; President-elect, The Transplantation Society.
Ascher NL| 2015-06-01 | PubMed
Improving interprofessional collaboration: evaluation of implicit attitudes in the surgeon-nurse relationship.
Braun HJ, O'Sullivan PS, Dusch MN, Antrum S, Ascher NL| 2014-12-12 | PubMed
Perceptions of surgeons: what characteristics do women surgeons prefer in a colleague?
Dusch MN, Braun HJ, O'Sullivan PS, Ascher NL| 2014-07-25 | PubMed
Patient perceptions of female surgeons: how surgeon demeanor and type of surgery affect patient preference.
Dusch MN, O'Sullivan PS, Ascher NL| 2013-10-17 | PubMed
Ex vivo split-liver transplantation: the true right/left split.
Vagefi PA, Parekh J, Ascher NL, Roberts JP, Freise CE| 2013-04-22 | PubMed
Left hepatectomy versus right hepatectomy for living donor liver transplantation: shifting the risk from the donor to the recipient.
Roll GR, Parekh JR, Parker WF, Siegler M, Pomfret EA, Ascher NL, Roberts JP| 2013-04-15 | PubMed
Asian American adolescents' willingness to donate organs and engage in family discussion about organ donation and transplantation.
Trompeta JA, Cooper BA, Ascher NL, Kools SM, Kennedy CM, Chen JL| 2012-03-01 | PubMed
Use of living donor liver transplantation varies with the availability of deceased donor liver transplantation.
Vagefi PA, Ascher NL, Freise CE, Dodge JL, Roberts JP| 2012-02-01 | PubMed
Outcomes with split liver transplantation in 106 recipients: the University of California, San Francisco, experience from 1993 to 2010.
Vagefi PA, Parekh J, Ascher NL, Roberts JP, Freise CE| 2011-09-01 | PubMed
Outcomes of surgical repair of bile leaks and strictures after adult-to-adult living donor liver transplant.
Melcher ML, Freise CE, Ascher NL, Roberts JP| 2010-11-01 | PubMed
Comparison of biliary complications in adult living-donor liver transplants performed at two busy transplant centers.
Melcher ML, Pomposelli JJ, Verbesey JE, McTaggart RA, Freise CE, Ascher NL, Roberts JP, Pomfret EA| 2010-09-01 | PubMed
Emergent orthotopic liver transplantation for hemorrhage from a giant cavernous hepatic hemangioma: case report and review.
Vagefi PA, Klein I, Gelb B, Hameed B, Moff SL, Simko JP, Fix OK, Eilers H, Feiner JR, Ascher NL, Freise CE, Bass NM| 2010-06-12 | PubMed
Development of the Organ Donation and Transplantation Knowledge Survey for use in Asian American adolescents.
Trompeta JA, Chen JL, Cooper BA, Ascher NL, Kools SM| 2010-06-01 | PubMed
Left lobe adult-to-adult living donor liver transplantation: small grafts and hemiportocaval shunts in the prevention of small-for-size syndrome.
Botha JF, Langnas AN, Campos BD, Grant WJ, Freise CE, Ascher NL, Mercer DF, Roberts JP| 2010-05-01 | PubMed
Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: an intention-to-treat analysis.
Yao FY, Kerlan RK, Hirose R, Davern TJ, Bass NM, Feng S, Peters M, Terrault N, Freise CE, Ascher NL, Roberts JP| 2008-09-01 | PubMed
Operating room assist: surgical mentorship and operating room experience for preclerkship medical students.
Cloyd J, Holtzman D, O'Sullivan P, Sammann A, Tendick F, Ascher N| 2008-07-01 | PubMed
Laparoscopic bariatric surgery improves candidacy in morbidly obese patients awaiting transplantation.
Takata MC, Campos GM, Ciovica R, Rabl C, Rogers SJ, Cello JP, Ascher NL, Posselt AM| 2008-03-04 | PubMed
Liver transplantation at UCSF--a 20-year experience.
Hirose R, Yao F, Stock P, Roberts J, Ascher N| 2008-01-01 | PubMed
HIV-infected liver and kidney transplant recipients: 1- and 3-year outcomes.
Roland ME, Barin B, Carlson L, Frassetto LA, Terrault NA, Hirose R, Freise CE, Benet LZ, Ascher NL, Roberts JP, Murphy B, Keller MJ, Olthoff KM, Blumberg EA, Brayman KL, Bartlett ST, Davis CE, McCune JM, Bredt BM, Stablein DM, Stock PG| 2007-12-18 | PubMed
Liver transplantation for hepatocellular carcinoma: validation of the UCSF-expanded criteria based on preoperative imaging.
Yao FY, Xiao L, Bass NM, Kerlan R, Ascher NL, Roberts JP| 2007-09-14 | PubMed
A surgical skills elective to expose preclinical medical students to surgery.
Sammann A, Tendick F, Ward D, Zaid H, O'Sullivan P, Ascher N| 2007-07-19 | PubMed
Tribute: Dr. Olga Jonasson. Born in Peoria, Illinois, August 12, 1934. Died in Chicago, Illinois, August 30, 2006.
Bartholomew A, Ascher N, Starzl T| 2007-06-18 | PubMed
Enhancing the mission of academic surgery by promoting scientific writing skills.
Derish PA, Maa J, Ascher NL, Harris HW| 2007-06-15 | PubMed
Central venous pressure monitoring during living right donor hepatectomy.
Niemann CU, Feiner J, Behrends M, Eilers H, Ascher NL, Roberts JP| 2007-02-01 | PubMed
A randomized trial of exercise and dietary counseling after liver transplantation.
Krasnoff JB, Vintro AQ, Ascher NL, Bass NM, Paul SM, Dodd MJ, Painter PL| 2006-08-01 | PubMed
Report of a National Conference on Donation after cardiac death.
Bernat JL, D'Alessandro AM, Port FK, Bleck TP, Heard SO, Medina J, Rosenbaum SH, Devita MA, Gaston RS, Merion RM, Barr ML, Marks WH, Nathan H, O'connor K, Rudow DL, Leichtman AB, Schwab P, Ascher NL, Metzger RA, Mc Bride V, Graham W, Wagner D, Warren J, Delmonico FL| 2006-02-01 | PubMed
A prospective study on downstaging of hepatocellular carcinoma prior to liver transplantation.
Yao FY, Hirose R, LaBerge JM, Davern TJ, Bass NM, Kerlan RK, Merriman R, Feng S, Freise CE, Ascher NL, Roberts JP| 2005-12-01 | PubMed
The Department of Surgery, University of California, San Francisco.
Derish P, Ascher NL| 2005-12-01 | PubMed
High incidence of recurrence and hematologic events following liver transplantation for Budd-Chiari syndrome.
Cruz E, Ascher NL, Roberts JP, Bass NM, Yao FY| 2005-08-01 | PubMed
The use of stents for duct-to-duct anastomoses of biliary reconstruction in orthotopic liver transplantation.
Kusano T, Randall HB, Roberts JP, Ascher NL| 2005-05-01 | PubMed
The impact of pre-operative loco-regional therapy on outcome after liver transplantation for hepatocellular carcinoma.
Yao FY, Kinkhabwala M, LaBerge JM, Bass NM, Brown R, Kerlan R, Venook A, Ascher NL, Emond JC, Roberts JP| 2005-04-01 | PubMed
Objective measures of health-related quality of life over 24 months post-liver transplantation.
Krasnoff JB, Vintro AQ, Ascher NL, Bass NM, Dodd MJ, Painter PL| 2005-02-01 | PubMed
Liver transplantation for hepatocellular carcinoma: lessons from the first year under the Model of End-Stage Liver Disease (MELD) organ allocation policy.
Yao FY, Bass NM, Ascher NL, Roberts JP| 2004-05-01 | PubMed
New onset diabetes mellitus after liver transplantation: the critical role of hepatitis C infection.
Khalili M, Lim JW, Bass N, Ascher NL, Roberts JP, Terrault NA| 2004-03-01 | PubMed
Split-liver transplantation in the United States: outcomes of a national survey.
Renz JF, Emond JC, Yersiz H, Ascher NL, Busuttil RW| 2004-02-01 | PubMed
Prediction of survival after liver retransplantation for late graft failure based on preoperative prognostic scores.
Yao FY, Saab S, Bass NM, Hirose R, Ly D, Terrault N, Lazar AA, Bacchetti P, Ascher NL, Roberts JP| 2004-01-01 | PubMed
Death from donor-transmitted malignancy despite emergency liver retransplantation.
Lipshutz GS, Baxter-Lowe LA, Nguyen T, Jones KD, Ascher NL, Feng S| 2003-10-01 | PubMed
Expanding the donor pool: can the Spanish model work in the United States?
Chang GJ, Mahanty HD, Ascher NL, Roberts JP| 2003-10-01 | PubMed
Effects of exercise training on coronary heart disease risk factors in renal transplant recipients.
Painter PL, Hector L, Ray K, Lynes L, Paul SM, Dodd M, Tomlanovich SL, Ascher NL| 2003-08-01 | PubMed
Kidney and liver transplantation in human immunodeficiency virus-infected patients: a pilot safety and efficacy study.
Stock PG, Roland ME, Carlson L, Freise CE, Roberts JP, Hirose R, Terrault NA, Frassetto LA, Palefsky JM, Tomlanovich SJ, Ascher NL| 2003-07-27 | PubMed
A follow-up analysis of the pattern and predictors of dropout from the waiting list for liver transplantation in patients with hepatocellular carcinoma: implications for the current organ allocation policy.
Yao FY, Bass NM, Nikolai B, Merriman R, Davern TJ, Kerlan R, Ascher NL, Roberts JP| 2003-07-01 | PubMed
Analysis of research projects in living donor organ transplantation.
Ascher NL| 2003-05-01 | PubMed
What's new in general surgery: transplantation.
Ascher NL| 2003-05-01 | PubMed
Intraoperative hemodynamics and liver function in adult-to-adult living liver donors.
Niemann CU, Roberts JP, Ascher NL, Yost CS| 2002-12-01 | PubMed
Liver transplantation for hepatocellular carcinoma: analysis of survival according to the intention-to-treat principle and dropout from the waiting list.
Yao FY, Bass NM, Nikolai B, Davern TJ, Kerlan R, Wu V, Ascher NL, Roberts JP| 2002-10-01 | PubMed
Liver transplantation for hepatocellular carcinoma: comparison of the proposed UCSF criteria with the Milan criteria and the Pittsburgh modified TNM criteria.
Yao FY, Ferrell L, Bass NM, Bacchetti P, Ascher NL, Roberts JP| 2002-09-01 | PubMed
Allograft rejection in pediatric liver transplantation: Comparison between cadaveric and living related donors.
Toyoki Y, Renz JF, Mudge C, Ascher NL, Roberts JP, Rosenthal P| 2002-08-01 | PubMed
A randomized trial of exercise training after renal transplantation.
Painter PL, Hector L, Ray K, Lynes L, Dibble S, Paul SM, Tomlanovich SL, Ascher NL| 2002-07-15 | PubMed
Donor health assessment after living-donor liver transplantation.
Diaz GC, Renz JF, Mudge C, Roberts JP, Ascher NL, Emond JC, Rosenthal P| 2002-07-01 | PubMed
Liver transplantation for nonviral, nonmalignant diseases:problem of recurrence.
Renz JF, Ascher NL| 2001-12-17 | PubMed
Posttransplantation growth in pediatric liver recipients.
Renz JF, de Roos M, Rosenthal P, Mudge C, Bacchetti P, Watson J, Roberts JP, Ascher NL, Emond JC| 2001-12-01 | PubMed
Solid organ transplantation in HIV-positive patients.
Stock P, Roland M, Carlson L, Freise C, Hirose R, Terrault N, Frassetto L, Coates T, Roberts J, Ascher N| 2001-11-01 | PubMed
Mixed allogeneic chimerism as a reliable model for composite tissue allograft tolerance induction across major and minor histocompatibility barriers.
Foster RD, Ascher NL, McCalmont TH, Neipp M, Anthony JP, Mathes SJ| 2001-09-15 | PubMed
Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival.
Yao FY, Ferrell L, Bass NM, Watson JJ, Bacchetti P, Venook A, Ascher NL, Roberts JP| 2001-06-01 | PubMed
Physical activity and health-related quality of life in liver transplant recipients.
Painter P, Krasnoff J, Paul SM, Ascher NL| 2001-03-01 | PubMed
Posttransplantation lymphoproliferative disorders in pediatric patients undergoing liver transplantation.
Koh BY, Rosenthal P, Medeiros LJ, Osorio RW, Roberts JP, Ascher NL, Gelb AB| 2001-03-01 | PubMed
Immunosuppressant substitutes in liver transplantation.
Ascher NL| 2001-02-24 | PubMed
A calcineurin inhibitor-sparing regimen with sirolimus, mycophenolate mofetil, and anti-CD25 mAb provides effective immunosuppression in kidney transplant recipients with delayed or impaired graft function.
Chang GJ, Mahanty HD, Vincenti F, Freise CE, Roberts JP, Ascher NL, Stock PG, Hirose R| 2000-12-01 | PubMed
Experience with the use of sirolimus in liver transplantation--use in patients for whom calcineurin inhibitors are contraindicated.
Chang GJ, Mahanty HD, Quan D, Freise CE, Ascher NL, Roberts JP, Stock PG, Hirose R| 2000-11-01 | PubMed
Surgical anatomy of the left lateral segment as applied to living-donor and split-liver transplantation: a clinicopathologic study.
Reichert PR, Renz JF, D'Albuquerque LA, Rosenthal P, Lim RC, Roberts JP, Ascher NL, Emond JC| 2000-11-01 | PubMed
Prolonged cold ischemia time obviates the benefits of 0 HLA mismatches in renal transplantation.
Lee CM, Carter JT, Alfrey EJ, Ascher NL, Roberts JP, Freise CE| 2000-09-01 | PubMed
A non-cleavable mutant of Fas ligand does not prevent neutrophilic destruction of islet transplants.
Kang SM, Braat D, Schneider DB, O'Rourke RW, Lin Z, Ascher NL, Dichek DA, Baekkeskov S, Stock PG| 2000-05-15 | PubMed
A dendritic cell line genetically modified to express CTLA4-IG as a means to prolong islet allograft survival.
O'Rourke RW, Kang SM, Lower JA, Feng S, Ascher NL, Baekkeskov S, Stock PG| 2000-04-15 | PubMed
Flow cytometry crossmatching as a predictor of acute rejection in sensitized recipients of cadaveric renal transplants.
O'Rourke RW, Osorio RW, Freise CE, Lou CD, Garovoy MR, Bacchetti P, Ascher NL, Melzer JS, Roberts JP, Stock PG| 2000-04-01 | PubMed
HCV-related fibrosis progression following liver transplantation: increase in recent years.
Berenguer M, Ferrell L, Watson J, Prieto M, Kim M, Rayón M, Córdoba J, Herola A, Ascher N, Mir J, Berenguer J, Wright TL| 2000-04-01 | PubMed
Experience with daclizumab in liver transplantation: renal transplant dosing without calcineurin inhibitors is insufficient to prevent acute rejection in liver transplantation.
Hirose R, Roberts JP, Quan D, Osorio RW, Freise C, Ascher NL, Stock PG| 2000-01-27 | PubMed
Liver transplantation for autoimmune hepatitis: rejection and recurrence.
Narumi S, Hakamada K, Sasaki M, Freise CE, Stock PG, Roberts JP, Ascher NL| 1999-08-01 | PubMed
Four-year follow-up of mycophenolate mofetil for graft rescue in liver allograft recipients.
Hebert MF, Ascher NL, Lake JR, Emond J, Nikolai B, Linna TJ, Roberts JP| 1999-03-15 | PubMed
Mycophenolate mofetil, microemulsion cyclosporine, and prednisone as primary immunosuppression for pediatric liver transplant recipients.
Renz JF, Lightdale J, Mudge C, Bacchetti P, Watson J, Ascher NL, Emond JC, Rosenthal P, Roberts JP| 1999-03-01 | PubMed
Effect of systemic cyclosporine on tumor recurrence after liver transplantation in a model of hepatocellular carcinoma.
Freise CE, Ferrell L, Liu T, Ascher NL, Roberts JP| 1999-02-27 | PubMed
Hepatic artery pseudoaneurysm with hemobilia following angioplasty after liver transplantation.
Narumi S, Osorio RW, Freise CE, Stock PG, Roberts JP, Ascher NL| 1998-12-01 | PubMed
Donor-specific tolerance induction in composite tissue allografts.
Foster RD, Fan L, Neipp M, Kaufman C, McCalmont T, Ascher N, Ildstad S, Anthony JP, Niepp M| 1998-11-01 | PubMed
Hepatitis after liver transplantation: the role of the known and unknown viruses.
Pessoa MG, Terrault NA, Ferrell LD, Detmer J, Kolberg J, Collins ML, Viele M, Lake JR, Roberts JP, Ascher NL, Wright TL| 1998-11-01 | PubMed
Possible recurrence of primary sclerosing cholangitis following living-related liver transplantation: report of a case.
Kita Y, Lake JR, Ferrell LD, Mori M, Roberts JP, Kakizoe S, Kiyosawa K, Tanaka E, Shiga J, Takikawa H, Inoue Y, Ohtake T, Ohtomo K, Yotsuyanagi H, Oka T, Harihara Y, Takayama T, Kubota K, Kawarasaki H, Hashikura Y, Kawasaki S, Ascher NL, Makuuchi M| 1998-11-01 | PubMed
Biliary complications of reduced-organ liver transplantation.
Reichert PR, Renz JF, Rosenthal P, Bacchetti P, Lim RC, Roberts JP, Ascher NL, Emond JC| 1998-09-01 | PubMed
Incidence and clinical consequences of surface and polymerase gene mutations in liver transplant recipients on hepatitis B immunoglobulin.
Terrault NA, Zhou S, McCory RW, Pruett TL, Lake JR, Roberts JP, Ascher NL, Wright TL| 1998-08-01 | PubMed
The role of pediatricians in the care of children with liver transplants.
Lightdale JR, Mudge CL, Ascher NL, Rosenthal P| 1998-08-01 | PubMed
Tolerance induction using bone marrow transplantation.
Ascher NL| 1998-07-01 | PubMed
Single-center long-term results of renal transplantation for IgA nephropathy.
Bumgardner GL, Amend WC, Ascher NL, Vincenti FG| 1998-04-27 | PubMed
Risks associated with conversion of stable patients after liver transplantation to the microemulsion formulation of cyclosporine.
Freise CE, Galbraith CA, Nikolai BJ, Ascher NL, Lake JR, Stock PG, Roberts JP| 1998-04-15 | PubMed
Fas ligand expression on islets as well as multiple cell lines results in accelerated neutrophilic rejection.
Kang SM, Lin Z, Ascher NL, Stock PG| 1998-03-01 | PubMed
Predictors of the cost of liver transplantation.
Brown RS, Lake JR, Ascher NL, Emond JC, Roberts JP| 1998-03-01 | PubMed
Progress in transgenic pigs for xenotransplantation.
Ascher NL| 1998-03-01 | PubMed
Quo vadis, my transplant fellow: a discussion of transplant surgery fellowship training activity in the United States and Canada: 1991-1997. Education Committee of the American Society of Transplant Surgeons.
Kaufman DB, Ascher NL| 1998-01-27 | PubMed
Interleukin-2 receptor antibody therapy.
Ascher NL| 1997-11-01 | PubMed
Pathological changes in yearly protocol liver biopsy specimens from healthy pediatric liver recipients.
Rosenthal P, Emond JC, Heyman MB, Snyder J, Roberts J, Ascher N, Ferrell L| 1997-11-01 | PubMed
The impact of surgical complications after liver transplantation on resource utilization.
Brown RS, Ascher NL, Lake JR, Emond JC, Bacchetti P, Randall HB, Roberts JP| 1997-10-01 | PubMed
Planned exploration of pediatric liver transplant recipients reduces posttransplant morbidity and lowers length of hospitalization.
Renz JF, Rosenthal P, Roberts JP, Ascher NL, Emond JC| 1997-09-01 | PubMed
Retransplantation of patients with severe posttransplant hepatitis B in the first allograft.
Ishitani M, McGory R, Dickson R, Caldwell S, Bickston S, McCullough C, Pruett T, Terrault N, Roberts J, Ascher N, Wright T, Lake J| 1997-08-15 | PubMed
Auxiliary liver transplant in fulminant failure.
Rosenthal P, Roberts JP, Ascher NL, Emond JC| 1997-08-01 | PubMed
Increased immune responses to regenerating partial liver grafts in the rat.
Omura T, Nakagawa T, Randall HB, Lin Z, Huey M, Ascher NL, Emond JC| 1997-06-01 | PubMed
Hepatitis G virus in patients with cryptogenic liver disease undergoing liver transplantation.
Pessoa MG, Terrault NA, Ferrell LD, Kim JP, Kolberg J, Detmer J, Collins ML, Yun AJ, Viele M, Lake JR, Roberts JP, Ascher NL, Wright TL| 1997-05-01 | PubMed
A controlled analysis of the transjugular intrahepatic portosystemic shunt in liver transplant recipients. The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Liver Transplantation Database.
Somberg KA, Lombardero MS, Lawlor SM, Ascher NL, Lake JR, Wiesner RH, Zetterman RK| 1997-04-27 | PubMed
The role of the host immune state in recurrent hepatitis C.
Ascher NL| 1997-03-01 | PubMed
Antibody to the host cellular gene-derived epitope GOR-1 in liver transplant recipients with hepatitis C virus infection.
Reiser M, Terrault N, Nelson DR, Mizokami M, Ferrell L, Lake JR, Roberts JP, Ascher NL, Wright TL, Lau JY| 1997-02-27 | PubMed
Clonal deletion is one mechanism responsible for tolerance in mixed hematopoietic chimeras.
Orloff SL, Hirose R, Lin Z, Narumi S, Stock PG, Ascher NL| 1997-02-01 | PubMed
Hepatitis G virus infection in patients with hepatitis C virus infection undergoing liver transplantation.
Berenguer M, Terrault NA, Piatak M, Yun A, Kim JP, Lau JY, Lake JR, Roberts JR, Ascher NL, Ferrell L, Wright TL| 1996-12-01 | PubMed
Prophylaxis in liver transplant recipients using a fixed dosing schedule of hepatitis B immunoglobulin.
Terrault NA, Zhou S, Combs C, Hahn JA, Lake JR, Roberts JP, Ascher NL, Wright TL| 1996-12-01 | PubMed
Severity of liver disease in liver transplantation recipients with hepatitis C virus infection: relationship to genotype and level of viremia.
Zhou S, Terrault NA, Ferrell L, Hahn JA, Lau JY, Simmonds P, Roberts JP, Lake JR, Ascher NL, Wright TL| 1996-11-01 | PubMed
Functional analysis of grafts from living donors. Implications for the treatment of older recipients.
Emond JC, Renz JF, Ferrell LD, Rosenthal P, Lim RC, Roberts JP, Lake JR, Ascher NL| 1996-10-01 | PubMed
Failure patterns of cryopreserved vein grafts in liver transplantation.
Kuang AA, Renz JF, Ferrell LD, Ring EJ, Rosenthal P, Lim RC, Roberts JP, Ascher NL, Emond JC| 1996-09-27 | PubMed
Liver transplantation improves survival of rats bearing hepatoma-3924A.
Roberts JP, Liu T, Freise CE, Mielczarek J, Ferrell L, Randall H, Ascher NL| 1996-09-01 | PubMed
SCID mouse as a model for transplantation studies.
Renz JF, Lin Z, de Roos M, Dalal AA, Ascher NL| 1996-09-01 | PubMed
Decreased mortality from technical failure improves results in pediatric liver transplantation.
Kuang AA, Rosenthal P, Roberts JP, Renz JF, Stock P, Ascher NL, Emond JC| 1996-08-01 | PubMed
Hepatotoxins and liver transplantation decrease pulmonary metastases in rats with hepatoma.
Freise CE, Liu T, Ascher NL, Roberts JP| 1996-08-01 | PubMed
Living related donor liver transplantation: the UCSF experience.
Emond JC, Rosenthal P, Roberts JP, Stock P, Kelley S, Gregory G, Lim RC, Ascher NL| 1996-08-01 | PubMed
Strategies for tolerance induction: potential applications in living donor liver transplantation.
Emond JC, Stock P, Roberts JP, Ascher NL| 1996-08-01 | PubMed
Fifty-percent partial liver transplantation in the rat.
Omura T, Ascher NL, Emond JC| 1996-07-27 | PubMed
Expanding the immunosuppressive repertoire.
Ascher NL| 1996-07-01 | PubMed
Advances in biliary reconstruction after liver transplantation.
Ascher NL| 1996-05-01 | PubMed
Interferon alfa for recurrent hepatitis B infection after liver transplantation.
Terrault NA, Holland CC, Ferrell L, Hahn JA, Lake JR, Roberts JP, Ascher NL, Wright TL| 1996-03-01 | PubMed
Transmission of hepatitis B virus through allotransplantation.
Gish RG, Ascher NL| 1996-03-01 | PubMed
United Network for Organ Sharing center-specific data: our report card.
Ascher NL| 1996-03-01 | PubMed
Incidence and significance of Aspergillus cultures following liver and kidney transplantation.
Brown RS, Lake JR, Katzman BA, Ascher NL, Somberg KA, Emond JC, Roberts JP| 1996-02-27 | PubMed
The use of the T tube after orthotopic liver transplantation.
Randall HB, Wachs ME, Somberg KA, Lake JR, Emond JC, Ascher NL, Roberts JP| 1996-01-27 | PubMed
Cryoglobulinemia presenting after liver transplantation.
Gournay J, Ferrell LD, Roberts JP, Ascher NL, Wright TL, Lake JR| 1996-01-01 | PubMed
Hepatitis C dilemma?
Ascher NL| 1996-01-01 | PubMed
Detection of hepatitis C after liver transplantation. Four serologic tests compared.
Donegan E, Wright TL, Roberts J, Ascher NL, Lake JR, Neuwald P, Wilber J, Quan S, Kuramoto IK, Dinello RK| 1995-12-01 | PubMed
Hepatic granulomas following liver transplantation. Clinicopathologic features in 42 patients.
Ferrell LD, Lee R, Brixko C, Bass NM, Lake JR, Roberts JP, Ascher N, Rabkin J| 1995-11-15 | PubMed
Increased efficacy of CSA following rearterialization in the rat OLTX model.
Freise CE, Liu T, Osorio RW, Ferrell L, Ascher NL, Roberts JP| 1995-10-01 | PubMed
Influence of donor age on graft survival after liver transplantation--United Network for Organ Sharing Registry.
Detre KM, Lombardero M, Belle S, Beringer K, Breen T, Daily OP, Ascher NL| 1995-09-01 | PubMed
Issues in xenotransplantation.
Ascher NL| 1995-09-01 | PubMed
Posttransplantation lymphoproliferative disorder in patients under primary tacrolimus (FK 506) immunosuppression.
Deschler DG, Osorio R, Ascher NL, Lee KC| 1995-09-01 | PubMed
Liver transplantation for sclerosing cholangitis.
Narumi S, Roberts JP, Emond JC, Lake J, Ascher NL| 1995-08-01 | PubMed
Total vascular exclusion for major hepatectomy in patients with abnormal liver parenchyma.
Emond J, Wachs ME, Renz JF, Kelley S, Harris H, Roberts JP, Ascher NL, Lim RC| 1995-08-01 | PubMed
Amelioration of acute GVHD disease and reestablishment of tolerance by short term treatment with anti TCR antibody.
Ascher NL| 1995-07-01 | PubMed
Liver transplantation for hepatocellular carcinoma: results with preoperative chemoembolization.
Venook AP, Ferrell LD, Roberts JP, Emond J, Frye JW, Ring E, Ascher NL, Lake JR| 1995-07-01 | PubMed
Primary sclerosing cholangitis: liver transplantation or biliary surgery.
Ascher NL| 1995-07-01 | PubMed
Time course of cyclosporine and ist motabolites in blood, liver and spleen of naive Lewis rats: comparison with preliminary data obtained in transplanted animals.
Wacher VJ, Liu T, Roberts JP, Ascher NL, Benet LZ| 1995-05-01 | PubMed
Two-year outcome following transjugular intrahepatic portosystemic shunt for variceal bleeding: results in 90 patients.
LaBerge JM, Somberg KA, Lake JR, Gordon RL, Kerlan RK, Ascher NL, Roberts JP, Simor MM, Doherty CA, Hahn J| 1995-04-01 | PubMed
Hepatocyte transplantation.
Ascher NL| 1995-03-01 | PubMed
FK506 (tacrolimus) compared with cyclosporine for primary immunosuppression after pediatric liver transplantation. Results from the U.S. Multicenter Trial.
McDiarmid SV, Busuttil RW, Ascher NL, Burdick J, D'Alessandro AM, Esquivel C, Kalayoglu M, Klein AS, Marsh JW, Miller CM| 1995-02-27 | PubMed
Impact of transjugular intrahepatic portosystemic shunts on liver transplantation: a controlled analysis. NIDDK Liver Transplantation Database.
Somberg KA, Lombardero MS, Lawlor SM, Ascher NL, Lake JR| 1995-02-01 | PubMed
The risk of transmission of hepatitis B from HBsAg(-), HBcAb(+), HBIgM(-) organ donors.
Wachs ME, Amend WJ, Ascher NL, Bretan PN, Emond J, Lake JR, Melzer JS, Roberts JP, Tomlanovich SJ, Vincenti F| 1995-01-27 | PubMed
Fulminant hepatic failure: summary of a workshop.
Hoofnagle JH, Carithers RL, Shapiro C, Ascher N| 1995-01-01 | PubMed
Immunosuppressive therapy in liver transplantation: principles and practice.
Ascher NL| 1995-01-01 | PubMed
Microchimerism in organ transplantation.
Ascher NL| 1995-01-01 | PubMed
Effect of cyclosporine dosing on creatinine levels in hepatic transplant recipients.
Gross CR, Savik SK, Ascher NL, Gordon RD, Klintmalm GB, Payne W, Shaw BW, Strasburg K, Parker A, Wiesner RH| 1994-10-01 | PubMed
Interferon-alpha therapy for hepatitis C virus infection after liver transplantation.
Wright TL, Combs C, Kim M, Ferrell L, Bacchetti P, Ascher N, Roberts J, Wilber J, Sheridan P, Urdea M| 1994-10-01 | PubMed
Liver transplantation for hepatitis C virus-related cirrhosis.
Ascher NL, Lake JR, Emond J, Roberts J| 1994-07-01 | PubMed
Predicting recidivism after orthotopic liver transplantation for alcoholic liver disease.
Osorio RW, Ascher NL, Avery M, Bacchetti P, Roberts JP, Lake JR| 1994-07-01 | PubMed
Enhancement of islet allograft survival in mice treated with MHC class I specific F(ab')2 alloantibody.
Osorio RW, Ascher NL, Melzer JS, Stock PG| 1994-04-01 | PubMed
Quantitation of hepatitis C virus RNA in liver transplant recipients.
Chazouilleres O, Kim M, Combs C, Ferrell L, Bacchetti P, Roberts J, Ascher NL, Neuwald P, Wilber J, Urdea M| 1994-04-01 | PubMed
beta-2 Microglobulin gene disruption prolongs murine islet allograft survival in NOD mice.
Osorio RW, Ascher NL, Melzer JS, Stock PG| 1994-04-01 | PubMed
Prolongation of in vivo mouse islet allograft survival by modulation of MHC class I antigen.
Osorio RW, Ascher NL, Stock PG| 1994-03-27 | PubMed
The increased efficacy and decreased nephrotoxicity of a cyclosporine liposome.
Freise CE, Liu T, Hong K, Osorio RW, Papahadjopoulos D, Ferrell L, Ascher NL, Roberts JP| 1994-03-27 | PubMed
"Occult" hepatitis B virus as source of infection in liver transplant recipients.
Chazouillères O, Mamish D, Kim M, Carey K, Ferrell L, Roberts JP, Ascher NL, Wright TL| 1994-01-15 | PubMed
Liver transplantation and the Najarian footprint.
Ascher NL| 1993-11-01 | PubMed
Major histocompatibility complex class I deficiency prolongs islet allograft survival.
Osorio RW, Ascher NL, Jaenisch R, Freise CE, Roberts JP, Stock PG| 1993-10-01 | PubMed
Reversal of chronic rejection after treatment failure with FK506 and RS61443.
Roberts JP, Lake JR, Hebert M, Nikolai B, Ascher NL, Ferrell LD| 1993-10-01 | PubMed
Immunosuppressive therapy as a determinant of transplantation outcomes.
Evans RW, Manninen DL, Dong FB, Ascher NL, Frist WH, Hansen JA, Kirklin JK, Perkins JD, Pirsch JD, Sanfilippo FP| 1993-06-01 | PubMed
Liver transplantation for fulminant hepatic failure.
Ascher NL, Lake JR, Emond JC, Roberts JP| 1993-06-01 | PubMed
New immunologic insights into mechanisms of allograft rejection.
Krams SM, Ascher NL, Martinez OM| 1993-06-01 | PubMed
Creation of transjugular intrahepatic portosystemic shunts with the wallstent endoprosthesis: results in 100 patients.
LaBerge JM, Ring EJ, Gordon RL, Lake JR, Doherty MM, Somberg KA, Roberts JP, Ascher NL| 1993-05-01 | PubMed
IL-2 and IL-5 gene expression in response to alloantigen in liver allograft recipients and in vitro.
Martinez OM, Villanueva JC, Lake J, Roberts JP, Ascher NL, Krams SM| 1993-05-01 | PubMed
Nonoperative management of biliary leaks after orthotopic liver transplantation.
Osorio RW, Freise CE, Stock PG, Lake JR, Laberge JM, Gordon RL, Ring EJ, Ascher NL, Roberts JP| 1993-05-01 | PubMed
Cirrhosis of undefined pathogenesis: absence of evidence for unknown viruses or autoimmune processes.
Greeve M, Ferrell L, Kim M, Combs C, Roberts J, Ascher N, Wright TL| 1993-04-01 | PubMed
Evidence for a nonclassical pathway of graft rejection involving interleukin 5 and eosinophils.
Martinez OM, Ascher NL, Ferrell L, Villanueva J, Lake J, Roberts JP, Krams SM| 1993-04-01 | PubMed
Hepatitis C and B in liver transplantation.
Lake JR, Wright T, Ferrell L, Donegan E, Roberts J, Ascher N| 1993-04-01 | PubMed
Immunosuppression and rejection in liver transplantation.
Ascher NL| 1993-04-01 | PubMed
Maintenance immunosuppression with prednisone and RS-61443 alone following liver transplantation.
Freise CE, Hebert M, Osorio RW, Nikolai B, Lake JR, Kauffman RS, Ascher NL, Roberts JP| 1993-04-01 | PubMed
Transjugular intrahepatic portacaval stent shunts in patients with renal insufficiency.
Lake JR, Ring E, LaBerge J, Gordon R, Roberts J, Ascher N| 1993-04-01 | PubMed
Estimates of organ-specific donor availability for the United States.
Orians CE, Evans RW, Ascher NL| 1993-02-01 | PubMed
Intragraft eosinophilia and interleukin-5 mRNA accompany liver allograft rejection.
Martinez OM, Krams SM, Villanueva JC, Ferrell L, Lake J, Roberts JP, Ascher NL| 1993-02-01 | PubMed
Isolation of functional MHC class I-deficient islet cells.
Osorio RW, Ascher NL, Jaenisch R, Natuzzi ES, Freise CE, Roberts JP, Stock PG| 1993-02-01 | PubMed
Orthotopic liver transplantation for end-stage alcoholic liver disease.
Osorio RW, Freise CE, Ascher NL, Roberts JP, Avery M, Lake JR| 1993-02-01 | PubMed
Prognostic factors for successful conversion from cyclosporine to FK 506-based immunosuppressive therapy for refractory rejection after liver transplantation. US Multicenter FK 506 Liver Study Group.
Klintmalm GB, Goldstein R, Gonwa T, Wiesner RH, Krom RA, Shaw BW, Stratta R, Ascher NL, Roberts JW, Lake J| 1993-02-01 | PubMed
RS-61443 for treatment-resistant human liver rejection.
Klintmalm GB, Ascher NL, Busuttil RW, Deierhoi M, Gonwa TA, Kauffman R, McDiarmid S, Poplawski S, Sollinger H, Roberts J| 1993-02-01 | PubMed
Standard sequential immunosuppression with Minnesota antilymphoblast globulin and cyclosporine vs FK 506: a comparison of early nephrotoxicity.
Stock PG, Ascher NL, Osorio RW, Tomlanovich S, Lake JR, Nikolai B, Freise C, Roberts JP| 1993-02-01 | PubMed
T-cell receptor-V alpha gene use in sequential liver allograft biopsies.
Krams SM, Martinez OM, Villanueva JC, Lake J, Roberts JP, Ascher NL| 1993-02-01 | PubMed
Use of FK 506 for the prevention of recurrent allograft rejection after successful conversion from cyclosporine for refractory rejection. US Multicenter FK 506 Liver Study Group.
Klintmalm GB, Goldstein R, Gonwa T, Wiesner RH, Krom RA, Shaw BW, Stratta R, Ascher NL, Roberts JW, Lake J| 1993-02-01 | PubMed
Use of Prograf (FK 506) as rescue therapy for refractory rejection after liver transplantation. US Multicenter FK 506 Liver Study Group.
Klintmalm GB, Goldstein R, Gonwa T, Wiesner RH, Krom RA, Shaw BW, Stratta R, Ascher NL, Roberts JW, Lake J| 1993-02-01 | PubMed
Liver transplantation at the University of California, San Francisco.
Ascher NL, Lake JR, Emond JC, Roberts JP| 1993-01-01 | PubMed
Incidence and diagnostic features of macroregenerative nodules vs. small hepatocellular carcinoma in cirrhotic livers.
Ferrell L, Wright T, Lake J, Roberts J, Ascher N| 1992-12-01 | PubMed
Lipopeliosis: fat induced sinusoidal dilatation in transplanted liver mimicking peliosis hepatis.
Ferrell L, Bass N, Roberts J, Ascher N| 1992-12-01 | PubMed
Hepatitis C viral infection in liver transplant recipients.
Ferrell LD, Wright TL, Roberts J, Ascher N, Lake J| 1992-10-01 | PubMed
Pulmonary hypertension associated with liver disease is not reversible after liver transplantation.
Prager MC, Cauldwell CA, Ascher NL, Roberts JP, Wolfe CL| 1992-08-01 | PubMed
Transjugular intrahepatic portosystemic shunts: preliminary results in 25 patients.
LaBerge JM, Ring EJ, Lake JR, Ferrell LD, Doherty MM, Gordon RL, Roberts JP, Peltzer MY, Ascher NL| 1992-08-01 | PubMed
A modified vascular "sleeve" anastomosis for rearterialization in orthotopic liver transplantation in rats.
Liu T, Freise CE, Ferrell L, Ascher NL, Roberts JP| 1992-07-01 | PubMed
Intracranial pressure monitoring and liver transplantation for fulminant hepatic failure.
Lidofsky SD, Bass NM, Prager MC, Washington DE, Read AE, Wright TL, Ascher NL, Roberts JP, Scharschmidt BF, Lake JR| 1992-07-01 | PubMed
Recurrent and acquired hepatitis C viral infection in liver transplant recipients.
Wright TL, Donegan E, Hsu HH, Ferrell L, Lake JR, Kim M, Combs C, Fennessy S, Roberts JP, Ascher NL| 1992-07-01 | PubMed
Hepatitis B virus and apparent fulminant non-A, non-B hepatitis.
Wright TL, Mamish D, Combs C, Kim M, Donegan E, Ferrell L, Lake J, Roberts J, Ascher NL| 1992-04-18 | PubMed
Cell subsets responding to purified hepatocytes and evidence of indirect recognition of hepatocyte major histocompatibility complex class I antigen. I. The role of L3T4+ T cells in the development of allospecific cytotoxicity in hepatocyte-sponge matrix a
Bumgardner GL, Chen S, Almond PS, Bach FH, Ascher NL, Matas AJ| 1992-04-01 | PubMed
Cell subsets responding to purified hepatocytes and evidence of indirect recognition of hepatocyte major histocompatibility complex class I antigen. II. In vitro-generated "memory" cells to class I+ class II- hepatocytes.
Bumgardner GL, Chen S, Almond PS, Bach FH, Ascher NL, Matas AJ| 1992-04-01 | PubMed
Using transjugular intrahepatic portosystemic shunts to control variceal bleeding before liver transplantation.
Ring EJ, Lake JR, Roberts JP, Gordon RL, LaBerge JM, Read AE, Sterneck MR, Ascher NL| 1992-02-15 | PubMed
Intragraft cytokine profile during human liver allograft rejection.
Martinez OM, Krams SM, Sterneck M, Villanueva JC, Falco DA, Ferrell LD, Lake J, Roberts JP, Ascher NL| 1992-02-01 | PubMed
Maintenance immunosuppression after liver transplantation.
Lake JR, Roberts JP, Ascher NL| 1992-02-01 | PubMed
The potential supply of organ donors. An assessment of the efficacy of organ procurement efforts in the United States.
Evans RW, Orians CE, Ascher NL| 1992-01-08 | PubMed
Anesthetic care of patients with Crigler-Najjar syndrome.
Prager MC, Johnson KL, Ascher NL, Roberts JP| 1992-01-01 | PubMed
Efficacy and toxicity of FK 506 for the treatment of resistant rejection in liver transplant patients.
Hebert MF, Ascher NL, Lake JR, Roberts JP| 1991-12-01 | PubMed
Similar clinical presentation of neurotoxicity following FK 506 and cyclosporine in a liver transplant recipient.
Freise CE, Rowley H, Lake J, Hebert M, Ascher NL, Roberts JP| 1991-12-01 | PubMed
Azathioprine hepatotoxicity after liver transplantation.
Sterneck M, Wiesner R, Ascher N, Roberts J, Ferrell L, Ludwig J, Lake J| 1991-11-01 | PubMed
Histopathologic study of transjugular intrahepatic portosystemic shunts.
LaBerge JM, Ferrell LD, Ring EJ, Gordon RL, Lake JR, Roberts JP, Ascher NL| 1991-11-01 | PubMed
Evidence for direct and indirect pathways in the generation of the alloimmune response against pancreatic islets.
Stock PG, Ascher NL, Chen S, Field J, Bach FH, Sutherland DE| 1991-10-01 | PubMed
Demonstration of local immunosuppression with methylprednisolone in the sponge matrix allograft model.
Freise CE, Clemmings S, Clemens LE, Alan T, Ashby T, Ashby E, Burke EC, Roberts JP, Ascher NL| 1991-08-01 | PubMed
Graft vs. host disease after liver transplantation in humans: a report of four cases.
Roberts JP, Ascher NL, Lake J, Capper J, Purohit S, Garovoy M, Lynch R, Ferrell L, Wright T| 1991-08-01 | PubMed
Hepatitis C virus not found in fulminant non-A, non-B hepatitis.
Wright TL, Hsu H, Donegan E, Feinstone S, Greenberg H, Read A, Ascher NL, Roberts JP, Lake JR| 1991-07-15 | PubMed
Early liver transplantation is indicated for tyrosinemia type I.
Freese DK, Tuchman M, Schwarzenberg SJ, Sharp HL, Rank JM, Bloomer JR, Ascher NL, Payne WD| 1991-07-01 | PubMed
Intrahepatic portocaval shunt for variceal hemorrhage prior to liver transplantation.
Roberts JP, Ring E, Lake JR, Sterneck M, Ascher NL| 1991-07-01 | PubMed
Cladosporium trichoides cerebral phaeohyphomycosis in a liver transplant recipient. Report of a case.
Aldape KD, Fox HS, Roberts JP, Ascher NL, Lake JR, Rowley HA| 1991-04-01 | PubMed
Hepatitis C in patients undergoing liver transplantation.
Read AE, Donegan E, Lake J, Ferrell L, Galbraith C, Kuramoto IK, Zeldis JB, Ascher NL, Roberts J, Wright TL| 1991-02-15 | PubMed
Allogeneic hepatocytes stimulate the production of immunoregulatory molecules in mixed lymphocyte hepatocyte cultures.
Martinez OM, Burke EC, Alan TJ, Ascher NL| 1991-02-01 | PubMed
An improved method for the detection of soluble interleukin 2 receptors in liver transplant recipients by flow cytometry.
Cohen N, Gumbert M, Birnbaum J, Lim VL, Falco D, Ascher N, Roberts J, Garovoy MR| 1991-02-01 | PubMed
Characterization of a cyclosporine-containing liposome.
Freise CE, Hong K, Clemens LE, Papahadjopoulos D, Burke E, Martinez O, Lake J, Ascher NL, Roberts JP| 1991-02-01 | PubMed
Comparison of ELISA and a flow cytometric method in the daily monitoring of soluble interleukin 2 receptors in liver transplant recipients.
Cohen N, Roberts J, Gumbert M, Birnbaum J, Lim VL, Falco D, Ascher N, Garovoy MR| 1991-02-01 | PubMed
Comparison of three regimens for cytomegalovirus prophylaxis in 147 liver transplant recipients.
Freise CE, Pons V, Lake J, Burke E, Ascher NL, Roberts JP| 1991-02-01 | PubMed
Hepatitis C in liver transplant recipients.
Read AE, Donegan E, Lake J, Ferrell L, Galbraith C, Kuramoto IK, Zeldis JB, Ascher NL, Roberts J, Wright TL| 1991-02-01 | PubMed
Lack of class II antigen expression on hepatocytes profoundly affects CTL development in vitro and in vivo.
Clemmings SM, Alan TJ, Bumgardner GL, Ascher NL| 1991-02-01 | PubMed
MHC expression on human hepatocytes before and after isolation.
Burke EC, Martinez OM, Freise CE, McVicar J, Roberts JP, Ascher NL| 1991-02-01 | PubMed
The alloimmune response against pancreatic islets is generated by both direct and indirect pathways.
Stock PG, Ascher NL, Chen S, Field J, Bach FH, Sutherland DE| 1991-02-01 | PubMed
Persistent hepatitis B virus following interferon alfa therapy and liver transplantation.
Lavine JE, Lake JR, Ascher NL, Ferrell LD, Ganem D, Wright TL| 1991-01-01 | PubMed
Percutaneous transhepatic portal vein angioplasty and stent placement after liver transplantation: early experience.
Olcott EW, Ring EJ, Roberts JP, Ascher NL, Lake JR, Gordon RL| 1990-11-01 | PubMed
Examination of vascular anastomoses during liver transplantation by intraoperative Doppler duplex scanning.
Roberts JP, Hughes L, Goldstone J, Ascher NL| 1990-08-01 | PubMed
Role of macrophages in the immune response to hepatocytes.
Bumgardner GL, Chen S, Almond SP, Ascher NL, Payne WD, Matas AJ| 1990-06-01 | PubMed
Liver transplantation for severe Amanita phalloides mushroom poisoning.
Pinson CW, Daya MR, Benner KG, Norton RL, Deveney KE, Ascher NL, Roberts JP, Lake JR, Kurkchubasche AG, Ragsdale JW| 1990-05-01 | PubMed
The management of T tube leaks in orthotopic liver transplant recipients with endoscopically placed nasobiliary catheters.
Ostroff JW, Roberts JP, Gordon RL, Ring EJ, Ascher NL| 1990-05-01 | PubMed
The alloimmune response to murine islets occurs via indirect antigen presentation to LYT2+ and L3T4+ lymphocytes.
Stock PG, Ascher NL, Chen S, Bumgardner G, Field MJ, Sutherland DE| 1990-04-01 | PubMed
Comparison of in vivo and in vitro immune response to purified hepatocytes.
Bumgardner GL, Matas AJ, Chen S, Cahill D, Cunningham TR, Payne WD, Bach FH, Ascher NL| 1990-02-01 | PubMed
Massive venous air embolism during orthotopic liver transplantation.
Prager MC, Gregory GA, Ascher NL, Roberts JP| 1990-01-01 | PubMed
Local prednisolone infusion of canine renal allografts.
Gruber SA, Hrushesky WJ, Canafax DM, Cipolle RJ, Burke BA, Matas AJ, Ascher NL, Simmons RL| 1989-12-01 | PubMed
The pharmacokinetic advantage of local 6-mercaptopurine infusion in a canine renal transplant model.
Gruber SA, Canafax DM, Erdmann GR, Cipolle RJ, Burke BA, Rabatin JT, Hynes PE, Gould FH, Heil JE, Ascher NL| 1989-12-01 | PubMed
Transplant renal artery stenosis.
Roberts JP, Ascher NL, Fryd DS, Hunter DW, Dunn DL, Payne WD, Sutherland DE, Castaneda-Zuniga W, Najarian JS| 1989-10-01 | PubMed
Gastric bezoar after hepatic transplantation.
Schwarzenberg SJ, Freese DK, Payne WD, Ascher NL, Sharp HL| 1989-07-01 | PubMed
Liver transplantation in a patient with protoporphyria.
Bloomer JR, Weimer MK, Bossenmaier IC, Snover DC, Payne WD, Ascher NL| 1989-07-01 | PubMed
Hemodynamic changes on clamping and unclamping of major vessels during liver transplantation.
Estrin JA, Belani KG, Ascher NL, Lura D, Payne W, Najarian JS| 1989-06-01 | PubMed
Selection criteria for liver transplantation donors.
Ascher NL| 1989-06-01 | PubMed
Modulation of MHC class I antigen decreases pancreatic islet immunogenicity.
Stock PG, Ascher NL, Chen S, Bumgardner GL, Field MJ, Sutherland DE| 1989-04-01 | PubMed
Biliary complications after liver transplantation in children.
Letourneau JG, Hunter DW, Ascher NL, Roberts JP, Payne WD, Thompson WM, Najarian JS, Castaneda-Zuniga WR, Day DL| 1989-03-01 | PubMed
Adult kidney retransplantation: evolution of treatment and results over 25 years at the University of Minnesota.
Fasola CG, Fryd DS, Fischel RJ, Ascher NL, Payne WD, Najarian JS| 1989-02-01 | PubMed
Comparative in vitro immunogenicity of cultured murine islets and hepatocytes.
Meloche M, Bumgardner G, Stock P, Chen S, Ascher NL, Sutherland DE| 1989-02-01 | PubMed
Factors influencing early survival after liver transplantation.
Stock PG, Estrin JA, Fryd DS, Payne WD, Belani KG, Elick BA, Najarian JS, Ascher NL| 1989-02-01 | PubMed
Frequency of precursor cytotoxic T lymphocytes correlates with outcome following heart-lung and pancreatic islet transplantation.
Stock PG, Clemmings SM, Han D, Sutherland DE, Ascher NL| 1989-02-01 | PubMed
Hereditary tyrosinemia type I (chronic form): pathologic findings in the liver.
Dehner LP, Snover DC, Sharp HL, Ascher N, Nakhleh R, Day DL| 1989-02-01 | PubMed
In vitro immunosuppressive effects of murine hepatocyte cytosol.
Bumgardner GL, Billiar T, So SK, Chen S, Dunn G, Payne W, Ascher NL| 1989-02-01 | PubMed
L3T4+,LyT2- and LyT2+,L3T4- T cells participate in the generation of allospecific cytotoxicity in response to MHC class I+ hepatocytes.
Bumgardner GL, Cahill DR, Chen S, Bach FH, Ascher NL| 1989-02-01 | PubMed
Long-term outcome of renal transplantation in patients with systemic lupus erythematosus.
Bumgardner GL, Mauer SM, Ascher NL, Payne WD, Dunn DL, Fryd DS, Sutherland DE, Simmons RL, Najarian JS| 1989-02-01 | PubMed
Pediatric liver transplantation across ABO blood group barriers.
Fischel RJ, Ascher NL, Payne WD, Freese DK, Stock P, Fasola C, Najarian JS| 1989-02-01 | PubMed
Rapid infusion technique as a safe alternative to veno-venous bypass in orthotopic liver transplant (TX).
Stock PG, Payne WD, Ascher NL, Roberts JP, Belani K, Estrin J, Najarian JS| 1989-02-01 | PubMed
Afferent and efferent pathways in T cell responses to MHC class I+, II-hepatocytes.
Bumgardner GL, Chen S, Hoffman R, Cahill DC, So SK, Platt J, Bach FH, Ascher NL| 1989-01-01 | PubMed
Effect of immunodepletion of MHC class II-positive cells from pancreatic islets on generation of cytotoxic T-lymphocytes in mixed islet-lymphocyte coculture.
Stock PG, Ascher NL, Platt JL, Kaufman DB, Chen S, Field MJ, Sutherland DE| 1989-01-01 | PubMed
Generation of allospecific cytolytic T-lymphocytes stimulated by pure pancreatic beta-cells in absence of Ia+ dendritic cells.
Stock PG, Meloche M, Ascher NL, Chen S, Bach FH, Sutherland DE| 1989-01-01 | PubMed
Liver transplantation today.
Roberts JP, Forsmark C, Lake JR, Ascher NL| 1989-01-01 | PubMed
Pharmacokinetics of 6-thiouric acid and 6-mercaptopurine in renal allograft recipients after oral administration of azathioprine.
Chan GL, Erdmann GR, Gruber SA, Stock P, Chen S, Ascher NL, Canafax DM| 1989-01-01 | PubMed
Responder T-cell subsets and antigenic stimulus in mixed lymphocyte-hepatocyte culture.
Bumgardner GL, Chen S, Hoffman R, Ascher NL| 1989-01-01 | PubMed
An implantable pump for intrarenal infusion of immunosuppressants in a canine autotransplant model.
Gruber SA, Cipolle RJ, Canafax DM, Erdmann GR, Burke BA, Rabatin JT, Hynes PE, Ritz JA, Gould FH, Ascher NL| 1988-12-01 | PubMed
Infection and rejection of primary hepatic transplant in 93 consecutive patients treated with triple immunosuppressive therapy.
Ascher NL, Stock PG, Bumgardner GL, Payne WD, Najarian JS| 1988-12-01 | PubMed
Orthotopic liver transplantation: nonoperative management of early, acute portal vein thrombosis.
Burke GW, Ascher NL, Hunter D, Najarian JS| 1988-11-01 | PubMed
Single-center 1-15-year results of renal transplantation in patients with systemic lupus erythematosus.
Bumgardner GL, Mauer SM, Payne W, Dunn DL, Sutherland DE, Fryd DS, Ascher NL, Simmons RL, Najarian JS| 1988-11-01 | PubMed
[Comparison of the results of liver transplantation in children and adults].
Bumgardner GL, Stock PG, Payne WD, Najarian JS, Ascher NL| 1988-08-01 | PubMed
Couette membrane filtration with constant shear stress.
Fischel RJ, Fischel H, Shatzel A, Lange WP, Cahill D, Gervais D, Ascher NL| 1988-07-01 | PubMed
In vitro generated allospecific cytolytic T lymphocytes injure pancreatic islets.
Stock PG, Ascher NL, Kaufman DB, Chen S, Meloche M, Field MJ, Sutherland DE| 1988-07-01 | PubMed
A single-center experience of renal transplantation in thirteen Jehovah's Witnesses.
Kaufman DB, Sutherland DE, Fryd DS, Ascher NL, Simmons RL, Najarian JS| 1988-06-01 | PubMed
Adjunctive azathioprine and antilymphocyte serum immunosuppression with cyclosporine.
Ford HR, Fryd DS, Canafax DM, Ascher NL, Dunn D, Sutherland DE, Najarian JS, Simmons RL| 1988-06-01 | PubMed
Effects of HLA matching in cadaver renal transplants.
Najarian JS, Migliori RJ, Simmons RL, Ascher NL, Payne WD, Dunn D, Sutherland DE, Fryd DS| 1988-06-01 | PubMed
Erythrocytosis and thromboembolic complications after renal transplantation: results from a randomized trial of cyclosporine versus azathioprine-antilymphocyte globulin.
Gruber SA, Simmons RL, Najarian JS, Vercellotti G, Ascher NL, Dunn DL, Payne WD, Sutherland DE, Fryd DS| 1988-06-01 | PubMed
Imaging of vascular complications after hepatic transplantation.
Dalen K, Day DL, Ascher NL, Hunter DW, Thompson WM, Castaneda-Zuniga WR, Letourneau JG| 1988-06-01 | PubMed
Biliary complications after liver transplantation in patients with preexisting sclerosing cholangitis.
Letourneau JG, Day DL, Hunter DW, Ascher NL, Najarian JS, Thompson WM, Castaneda-Zuniga WR| 1988-05-01 | PubMed
Pancreatic islets generate allospecific cytolytic T lymphocytes in a mixed lymphocyte-islet culture.
Stock P, Ascher N, Chen S, Field J, Platt J, Kaufman D, Sutherland D| 1988-05-01 | PubMed
Imaging of renal transplants.
Letourneau JG, Day DL, Ascher NL, Castaneda-Zuniga WR| 1988-04-01 | PubMed
Lymphocyte traffic and distribution after sponge matrix allograft using limiting dilution analysis.
Ascher NL, Clemmings SM, Cahill DR, Hoffman RA| 1988-04-01 | PubMed
The contribution of natural killer cells to the allograft response.
Hoffman RA, Jordan ML, Ascher NL, Simmons RL| 1988-04-01 | PubMed
Characterization of natural killer activity in sponge matrix allografts.
Hoffman RA, Ascher NL, Jordan ML, Migliori RJ, Simmons RL| 1988-03-01 | PubMed
A randomized trial comparing cyclosporine with antilymphoblast-globulin-azathioprine for renal allograft recipients. Results at 2 1/2-6 years.
Johnson CP, Simmons RL, Sutherland DE, Canafax DM, Ascher NL, Payne WD, Flick B, Najarian JS, Fryd DS| 1988-02-01 | PubMed
Failure of freshly inplanted alloantigen in vivo to attract circulating allosensitized lymphocytes.
Migliori RJ, Hoffman RA, Gruber SA, Debe EC, Ascher NL, Simmons RL| 1988-02-01 | PubMed
ABO-compatible mismatching decreases 5-year actuarial graft survival after renal transplantation.
Stock PG, Sutherland DE, Fryd DS, Ascher NL, Payne W, Simmons RL, Najarian JS| 1987-12-01 | PubMed
Thromboembolic complications in renal allograft recipients. A report from the prospective randomized study of cyclosporine versus azathioprine-antilymphocyte globulin.
Gruber SA, Pescovitz MD, Simmons RL, Najarian JS, Ascher NL, Payne WD, Sutherland DE, Fryd DS| 1987-12-01 | PubMed
Mixed islet-lymphocyte culture as a model for pancreatic islet immunogenicity and cell-mediated immune injury.
Stock P, Ascher N, Kaufman D, Sutherland D| 1987-10-01 | PubMed
Suppression of macrophage-mediated lymphocyte recruitment by local but not systemic steroids.
Gruber SA, Migliori RJ, Hoffman RA, Ascher NL, Simmons RL| 1987-09-01 | PubMed
The impact of cyclosporine and combination immunosuppression on the incidence of posttransplant diabetes in renal allograft recipients.
Boudreaux JP, McHugh L, Canafax DM, Ascher N, Sutherland DE, Payne W, Simmons RL, Najarian JS, Fryd DS| 1987-09-01 | PubMed
Abdominal sonography after hepatic transplantation: results in 36 patients.
Letourneau JG, Day DL, Ascher NL, Snover DC, Steely JW, Crass JR, Najarian JS, Feinberg SB| 1987-08-01 | PubMed
Hepatic regenerating nodules in hereditary tyrosinemia.
Day DL, Letourneau JG, Allan BT, Sharp HL, Ascher N, Dehner LP, Thompson WM| 1987-08-01 | PubMed
Major histocompatibility complex class I antigens on hepatocytes in human liver grafts.
Platt JL, Ascher NL, Snover DC, So SK| 1987-08-01 | PubMed
Pediatric liver transplantation using combination immunosuppressive therapy.
Stock PG, Ascher NL, Najarian JS| 1987-08-01 | PubMed
Reperfusion coagulopathy during human liver transplantation.
Bellani KG, Estrin JA, Ascher NL, Najarian JS, Bushman J, Buckley JJ| 1987-08-01 | PubMed
Liver allograft transplantation: postoperative CT findings.
Letourneau JG, Day DL, Maile CW, Crass JR, Ascher NL, Frick MP| 1987-06-01 | PubMed
Hepatitis-associated aplastic anemia after liver transplantation.
Stock PG, Steiner ME, Freese D, Sharp H, Ascher NL| 1987-04-01 | PubMed
Kidney transplantation in diabetic patients.
Sutherland DE, Fryd DS, Payne WD, Ascher N, Simmons RL, Najarian JS| 1987-04-01 | PubMed
Contribution of extrahepatic tissues to biochemical abnormalities in hereditary tyrosinemia type I: study of three patients after liver transplantation.
Tuchman M, Freese DK, Sharp HL, Ramnaraine ML, Ascher N, Bloomer JR| 1987-03-01 | PubMed
Ultrasound and computed tomographic evaluation in hepatic transplantation.
Letourneau JG, Day DL, Frick MP, Steely JW, Maile CW, Ascher NL, Feinberg SB| 1987-03-01 | PubMed
An analysis of histological prognostic features of liver allograft rejection based on 270 serial biopsies.
Snover DC, Freese DK, Bloomer JR, Sharp HL, Ascher NL| 1987-02-01 | PubMed
Can renal transplantation be done safely without prior dialysis therapy?
Fryd D, Migliori RJ, Ascher NL, Payne W, Sutherland DE, Simmons R, Najarian JS| 1987-02-01 | PubMed
Class I major histocompatibility complex antigens are induced on hepatocytes in rejecting human liver grafts.
So SK, Snover DC, Ascher NL, Platt JL| 1987-02-01 | PubMed
Cloned T cells do not require host H-2 restrictions to elicit delayed-type hypersensitivity.
Cahill DR, Hoffman RA, Clemmings SM, Simmons RL, Ascher NL| 1987-02-01 | PubMed
Compartmentalization and lymphocyte traffic after allograft challenge.
Clemmings SM, Hoffman RA, Cahill DR, Simmons RL, Ascher NL| 1987-02-01 | PubMed
Cox regression analysis of outcome risk factors in 519 renal allograft recipients.
Canafax DM, Savik SK, Draxler CA, Le CT, Ascher NL, Payne WD, Sutherland DE, Migliori RJ, Simmons RL, Najarian JS| 1987-02-01 | PubMed
Designation of liver transplant centers in the United States.
Ascher NL, Evans RW| 1987-02-01 | PubMed
Detrimental effect of ABO mismatching in renal transplantation.
Stock P, Sutherland DE, Fryd DS, Ascher NL, Payne WD, Simmons RL, Najarian JS| 1987-02-01 | PubMed
Effector mechanisms in allograft rejection.
Ascher NL| 1987-02-01 | PubMed
First kidney transplants in children 5 years of age or younger.
Najarian JS, So SK, Simmons RL, Mauer SM, Nevins TE, Sutherland DE, Ascher NL, Chavers BM, Payne WD, Fryd DS| 1987-02-01 | PubMed
Frequency of diabetes-related complications in renal allograft recipients prospectively randomized to cyclosporine or azathioprine.
Pescovitz MD, Gruber SA, Ascher NL, Kruse LV, Najarian JS, Payne WD, Simmons RL, Sutherland DE, Fryd DS| 1987-02-01 | PubMed
HLA-DR tissue typing may be ignored for first but not subsequent cadaver renal transplants.
Migliori RJ, Simmons RL, Fryd D, Noreen H, Ascher NL, Sutherland DE, Payne W, Najarian JS| 1987-02-01 | PubMed
In vivo macrophage-directed lymphocyte traffic requires macrophage activation.
Migliori RJ, Hoffman R, Debe E, Ascher NL, Simmons RL| 1987-02-01 | PubMed
Plasma amino acid clearance predicts hepatic recovery after normothermic anoxia and cold preservation.
Becker WK, Stock P, Fath JJ, Konstantinides FN, Ascher NL, Cerra FB| 1987-02-01 | PubMed
Prognostic perioperative factors predicting the outcome of liver transplantation.
Stock PG, Estrin JA, Fryd DS, Payne WD, Belani KG, Elick BA, Najarian JS, Ascher NL| 1987-02-01 | PubMed
Purified hepatocytes can stimulate allospecific cytolytic T lymphocytes in a mixed lymphocyte-hepatocyte culture.
So SK, Wilkes LM, Platt JL, Ascher NL, Simmons RL| 1987-02-01 | PubMed
Renal allograft survival in patients with positive donor-specific B lymphocyte crossmatches.
Noreen HJ, van der Hagen E, Bach FH, Fryd D, Ascher N, Simmons RL, Najarian JS| 1987-02-01 | PubMed
The role of natural killer cells in the allograft response.
Hoffman RA, Jordan ML, Ascher NL, Simmons RL| 1987-02-01 | PubMed
Thromboembolic complications after renal transplantation: results from the randomized trial of cyclosporine v azathioprine-antilymphocyte globulin.
Gruber SA, Pescovitz M, Simmons RL, Najarian JS, Ascher NL, Payne WD, Sutherland DE, Elick B, Fryd DS| 1987-02-01 | PubMed
Use of triple therapy and percutaneous needle biopsy to minimize graft failure following liver transplantation.
St Cyr JA, Elick B, Freese D, Sharp H, Payne W, Bloomer J, Stock P, Snover D, Najarian JS, Ascher NL| 1987-02-01 | PubMed
Increased expression of class I major histocompatibility complex antigens on hepatocytes in rejecting human liver allografts.
So SK, Platt JL, Ascher NL, Snover DC| 1987-01-01 | PubMed
Liver allograft rejection. An analysis of the use of biopsy in determining outcome of rejection.
Snover DC, Freese DK, Sharp HL, Bloomer JR, Najarian JS, Ascher NL| 1987-01-01 | PubMed
Renal transplantation done safely without prior chronic dialysis therapy.
Migliori RJ, Simmons RL, Payne WD, Ascher NL, Sutherland DE, Najarian JS, Fryd D| 1987-01-01 | PubMed
MR evaluation of the portal vein in pediatric liver transplant candidates.
Day DL, Letourneau JG, Allan BT, Ascher NL, Lund G| 1986-11-01 | PubMed
The outcome of 304 primary renal transplants in children (1968-1985).
Najarian JS, So SK, Simmons RL, Fryd DS, Nevins TE, Ascher NL, Sutherland DE, Payne WD, Chavers BM, Mauer SM| 1986-09-01 | PubMed
Lymphocytes capable of mediating delayed-type hypersensitivity reactions accumulate within sponge matrix allografts.
Ascher NL, Cahill DR, Hoffman RA, Simmons RL| 1986-08-01 | PubMed
Current results in pediatric renal transplantation at the University of Minnesota.
So SK, Mauer SM, Nevins TE, Fryd DS, Sutherland DE, Ascher NL, Simmons RL, Najarian JS| 1986-07-01 | PubMed
Fulminant Wilson's disease treated with postdilution hemofiltration and orthotopic liver transplantation.
Rakela J, Kurtz SB, McCarthy JT, Ludwig J, Ascher NL, Bloomer JR, Claus PL| 1986-06-01 | PubMed
Early and late effects of two immunosuppressive drug protocols on recipients of renal allografts: results of the Minnesota randomized trial comparing cyclosporine versus antilymphocyte globulin-azathioprine.
Canafax DM, Simmons RL, Sutherland DE, Fryd DS, Strand MH, Ascher NL, Payne WD, Najarian JS| 1986-04-01 | PubMed
New immunosuppressive drug combinations for mismatched related and cadaveric renal transplantation.
Simmons RL, Canafax DM, Fryd DS, Ascher NL, Payne WD, Sutherland DE, Najarian JS| 1986-04-01 | PubMed
Renal transplant immunity and immunosuppression.
McEnery PT, Fine R, Ascher N, Ettenger R, Conley S, Friedman J, Tejani A| 1986-04-01 | PubMed
Scintigraphic evaluation of liver transplant function.
Loken MK, Ascher NL, Boudreau RJ, Najarian JS| 1986-04-01 | PubMed
The effects of delayed function on recipients of cadaver renal allografts. A study of 158 patients randomized to cyclosporine or ALG-azathioprine.
Canafax DM, Torres A, Fryd DS, Heil JE, Strand MH, Ascher NL, Payne WD, Sutherland DE, Simmons RL, Najarian JS| 1986-02-01 | PubMed
The migration of activated T lymphocytes in vitro. III. Paralysis and recovery of locomotor function during mitosis.
Hoffman RA, Hyland BJ, Ascher NL, Simmons RL| 1986-02-01 | PubMed
Alterations in amino acid clearance during ischemia predict hepatocellular ATP changes.
Fath JJ, St Cyr JA, Konstantinides FN, Alden P, Ascher NL, Bianco RW, Foker JE, Cerra FB| 1985-09-01 | PubMed
Management and prevention of cyclosporine nephrotoxicity after renal transplantation: use of low doses of cyclosporine, azathioprine, and prednisone.
Simmons RL, Canafax DM, Strand M, Ascher NL, Payne WD, Sutherland DE, Najarian JS| 1985-08-01 | PubMed
Results of the Minnesota randomized prospective trial of cyclosporine versus azathioprine-antilymphocyte globulin for immunosuppression in renal allograft recipients.
Sutherland DE, Fryd DS, Strand MH, Canafax DM, Ascher NL, Payne WD, Simmons RL, Najarian JS| 1985-06-01 | PubMed
A single institution, randomized, prospective trial of cyclosporin versus azathioprine-antilymphocyte globulin for immunosuppression in renal allograft recipients.
Najarian JS, Fryd DS, Strand M, Canafax DM, Ascher NL, Payne WD, Simmons RL, Sutherland DE| 1985-02-01 | PubMed
Information and long-term follow-up of a large number of related kidney donors at a single institution.
Sutherland DE, Weiland D, Chavers B, Simmons RL, Ascher NL, Najarian JS| 1985-01-01 | PubMed
Persistent succinylacetone excretion after liver transplantation in a patient with hereditary tyrosinaemia type I.
Tuchman M, Freese DK, Sharp HL, Whitley CB, Ramnaraine ML, Ulstrom RA, Najarian JS, Ascher N, Buist NR, Terry AB| 1985-01-01 | PubMed
Studies on living related kidney donors at a single institution.
Najarian JS, Weiland D, Chavers B, Simmons RL, Payne WD, Ascher NL, Sutherland DE| 1985-01-01 | PubMed
A functional assay for cyclosporine in patient serum.
Orosz CG, Ferguson RM, Olson S, Ascher N| 1984-12-01 | PubMed
Comparison of modes of action of different immunosuppressive agents.
Olson SA, Ascher NL, Orosz CG, Najarian JS| 1984-12-01 | PubMed
Long-term effect of splenectomy versus no splenectomy in renal transplant patients. Reanalysis of a randomized prospective study.
Sutherland DE, Fryd DS, So SK, Bentley FR, Ascher NL, Simmons RL, Najarian JS| 1984-12-01 | PubMed
Similar renal allograft functional survival rates for kidneys from sibling donors matched for zero-versus-one haplotype with the recipient.
Bentley FR, Sutherland DE, Fryd DS, Kaufman D, Ascher NL, Simmons RL, Najarian JS| 1984-12-01 | PubMed
Liver transplantation.
Najarian JS, Ascher NL| 1984-11-01 | PubMed
Orthotopic liver transplantation: a pathological study of 63 serial liver biopsies from 17 patients with special reference to the diagnostic features and natural history of rejection.
Snover DC, Sibley RK, Freese DK, Sharp HL, Bloomer JR, Najarian JS, Ascher NL| 1984-11-01 | PubMed
Survival rates of 2,728 patients with end-stage renal disease.
Hellerstedt WL, Johnson WJ, Ascher N, Kjellstrand CM, Knutson R, Shapiro FL, Sterioff S| 1984-11-01 | PubMed
Metabolism during hepatic transplantation: indicators of allograft function.
Fath JJ, Ascher NL, Konstantinides FN, Bloomer J, Sharp H, Najarian JS, Cerra FB| 1984-10-01 | PubMed
Results of renal transplantation in diabetics at the University of Minnesota since 1979, including a comparison of outcome in diabetic and nondiabetic recipients randomized to cyclosporine versus azathioprine for immunosuppression.
Sutherland DE, Fryd DS, Strand M, Ascher N, Simmons RL, Najarian JS| 1984-06-01 | PubMed
Comparison of azathioprine-antilymphocyte globulin versus cyclosporine in renal transplantation.
Sutherland DE, Strand M, Fryd DS, Ferguson RM, Simmons RL, Ascher NL, Najarian JS| 1984-05-01 | PubMed
Hepatic transplantation and biliary atresia: early experience in eight patients.
Ascher NL, Najarian JS| 1984-02-01 | PubMed
Cellular basis of allograft rejection.
Ascher NL, Hoffman RA, Hanto DW, Simmons RL| 1984-01-01 | PubMed
Cyclosporine immunosuppression.
Canafax DM, Ascher NL| 1983-11-01 | PubMed
Maturation of cytotoxic T cells within sponge matrix allografts.
Ascher NL, Chen S, Hoffman RA, Simmons RL| 1983-08-01 | PubMed
The community physician and liver transplantation.
Sharp HL, Ascher NL| 1983-08-01 | PubMed
The migration of activated murine T lymphocytes in vitro. II. Evidence for differential locomotion of T cell subsets.
Hoffman RA, Ascher NL, Hanto DW, Simmons RL| 1983-04-01 | PubMed
Cellular events within the rejecting allograft.
Ascher NL, Hoffman R, Hanto DW, Simmons RL| 1983-03-01 | PubMed
Maturation of cytotoxic effector cells at the site of allograft rejection.
Ascher NL, Chen S, Hoffman R, Simmons RL| 1981-03-01 | PubMed
Migration of mouse lymphocytes in vitro. I. Normal lymph node lymphocytes.
Hoffman RA, Ascher NL, Nelson RD, Simmons RL| 1981-03-01 | PubMed
Migratory behavior of lymphocytes during allograft rejection.
Hoffman RA, Ascher NL, Simmons RL| 1981-03-01 | PubMed
Evidence for local helper and suppressor function at the site of allograft rejection.
Ascher NL, Hoffman R, Chen S, Simmons RL| 1980-08-01 | PubMed
Radiolabeled autologous leukocyte scanning in abscess detection.
Ascher NL, Forstrom L, Simmons RL| 1980-07-01 | PubMed
Specific and nonspecific infiltration of sponge matrix allografts by specifically sensitized cytotoxic lymphocytes.
Ascher NL, Hoffman R, Chen S, Simmons RL| 1980-06-01 | PubMed
Effects of HLA-A and B matching on success of cadaver grafts at a single center.
Ascher NL, Simmons RL, Fryd D, Noreen H, Najarian JS| 1979-09-01 | PubMed
Epstein-Barr virus antibody responses and clinical illness in renal transplant recipients.
Marker SC, Ascher NL, Kalis JM, Simmons RL, Najarian JS, Balfour HH| 1979-04-01 | PubMed
Indium 111 autologous tagged leukocytes in the diagnosis of intraperitoneal sepsis.
Ascher NL, Ahrenholz DH, Simmons RL, Weiblen B, Gomez L, Forstrom LA, Frick MP, Henke C, McCullough J| 1979-04-01 | PubMed
Partial characterization of cytotoxic cells infiltrating sponge matrix allografts.
Ascher NL, Ferguson RM, Hoffman R, Simmons RL| 1979-04-01 | PubMed
Causes and management of rejection.
Najarian JS, Ascher NL| 1979-03-01 | PubMed
Relative absence of helper cells in rejecting allografts.
Ascher NL, Hoffman R, Simmons RL| 1979-03-01 | PubMed
100 HLA-identical sibling transplants. Prognostic factors other than histocompatibility.
Ascher NL, Simmons RL, Noreen H, VanHook J, Howard RJ, Sutherland DE, Najarian JS| 1979-02-01 | PubMed
100 second renal allografts from a single transplantation institution.
Ascher NL, Ahrenholz DH, Simmons RL, Najarian JS| 1979-01-01 | PubMed
Graft rejection in donor-recipient pairs with differing of H-2 loci.
Chen S, Ascher NL, Bach FH, Simmons RL| 1979-01-01 | PubMed
Local graft irradiation: effect on cytotoxic cell infiltration.
Ascher NL, Hoffman RA, Simmons RL| 1979-01-01 | PubMed
Jaundice after renal allotransplantation.
Mozes MF, Ascher NL, Balfour HH, Simmons RL, Najarian JS| 1978-12-01 | PubMed
Tuberculous joint disease in transplant patients.
Ascher NL, Simmons RL, Marker S, Klugman J, Najarian JS| 1978-06-01 | PubMed
Listeria infection in transplant patients. Five cases and a review of the literature.
Ascher NL, Simmons RL, Marker S, Najarian JS| 1978-01-01 | PubMed
Superior results of well matched cadaveric grafts as compared to parental grafts.
Ascher NL, Simmons RL, Fryd DS, Najarian JS| 1977-01-01 | PubMed
Cryopreservation of vein grafts.
Dent TL, Weber TR, Lindenauer SM, Ascher N, Weatherbee L, Allen E, Spencer HH| 1974-01-01 | PubMed

Resources

Resources

Address

Websites

Biography

Videos

Education

Board Certifications

Clinical Expertise

Grants and Funding

Research Narrative

Research Interests

Publications